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Abstract 
Systems for the development of skeletal muscle tissue in vitro can be used to study muscle 
tissue development and pathophysiology.  Many systems for the development of myofibers involve 
the presence of a scaffold, which can be a physical barrier to cell proliferation and cause 
incongruities within the myofiber.  We developed a system by which myogenic cells can be seeded 
within a mold to form a myofiber without the need for a scaffold.  A “dog” bone shaped double 
negative mold made of acrylic was used to form a final agarose mold.  Experiments were conducted 
to compare the seeding of only C2C12 mouse myoblast cells versus myoblast cells embedded in 
fibrin or collagen gels.  Tissue formation in the no-gel system was observed one day post-seeding, 
while minor incongruities were seen in the fibrin gel system and major breaks in the tissue were 
found in the collagen gel system.  C2C12 cells were characterized using BrdU staining to find the 
optimal time point after induction of differentiation for seeding and showed that differentiation 
occurs at Day 4 post-induction.  Myosin staining of C2C12 cells seeded on plates confirmed 
maturation of the formed myofibers.  Further studies in optimizing the molding system should focus 
on improved manufacture of the mold to enhance the long-term stability of the myofiber.   
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Chapter 1: Introduction 
In all individuals, skeletal muscle damage and repair occur continuously when physical 
stresses from daily activities are exerted on the muscle.  For the muscle to repair itself, satellite 
cells, which are progenitor cells found within muscle fibers, are released from the basement 
membrane and are activated to proliferate, then differentiate and fuse into myotubes.  Some of 
the satellite cells remain undifferentiated to maintain the sateliite cell pool.  The new myotubes 
then integrate with the surrounding undamaged skeletal muscle and then mature into 
myofibers.  Ideally, the newly formed skeletal muscle will proceed to become innervated and 
mechanically linked to bone via tendons in order to resume full functionality.   
On a large scale, skeletal muscle damage can be caused by atrophy, disease, or injury.  
In these cases, the extent of the damage often makes it difficult for the muscle to naturally 
regenerate completely.  During the repair process, fibroblasts deposit collagen and other 
extracellular matrix proteins, which contribute to the formation of scar-tissue.  If fibrosis 
occurs, the repaired muscle will have significantly decreased functionality since the scar tissue 
affects the strength of the muscle contraction and the elasticity of the muscle.  Transplantation 
of muscle fibers into the damaged region can allow the fibers to incorporate with the existing 
fibers and potentially reduce the amount of fibrosis that occurs during the natural regeneration 
process.    
The current system of creating muscle fibers involves seeding of cells onto collagen or 
fibrin microthreads using a rotational seeding system.  However, the effectiveness of this 
system is limited by the inability of the cells on the surface of the microthread to proliferate 
throughout the center of the microthread to accurately recapitulate the structure of a muscle 
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fiber.  Thus, creating a system that involves a channel within a mold that will guide cells with 
myogenic potential to align in the appropriate formation to develop muscle fibers may be a 
more effective method of creating muscle fibers that are comparable to those found within the 
body.  The molding system would also allow for precise control over physical characteristics of 
length and width of the myofiber and will provide optimal uniformity of mechanical properties 
through the length of the myofiber.  
By enclosing the cells within a biological gel matrix and seeding this gel within the 
seeding channel, the cells will receive the benefits of the biological cues provided by the gel and 
will be able to degrade the gel over time as they form their own ECM which penetrates 
throughout the volume of the channel.  Two anchor points, one on either end of the seeding 
channel, will provide support for the cells to grow around and pull on each other to maintain 
tension throughout the fiber.  This tension will promote optimal alignment of the myofiber and 
will prevent collapse of the myofiber as the cells contract upon each other.  
In the following chapters of the project report, a summary of current approaches used 
in skeletal muscle regeneration and potential future advancements is presented.  The report 
also describes the project strategy by including a breakdown of the client statement presented 
to the design team and the approach that the design team took to develop a solution to the 
client statement.  The report then describes alternative designs that were explored during the 
design process and the analytical tools that were used to evaluate and determine the design 
that best meets the criteria established by the client and the user.  The design verification 
chapter of the report presents data and findings from the testing of the system.  This section is 
followed by a discussion of the results and the final design validation.  The next chapter relates 
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the group’s results in context of the current approaches discussed in the literature review.  
Also, the report contains experimental methods for validation of the design that can be used by 
future project groups.  The final section contains conclusions about the results and 
recommendations for future work. 
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2. Literature Review 
2.1 Structure of Skeletal Muscle 
The human body is characterized by 660 skeletal muscles, which are composed of 
hundreds to thousands of individual muscle fibers.  The smallest muscle in the body, the tensor 
tympani, which is found in the ear, contains a few hundred muscle fibers, while the largest 
muscle of the body, the medial gastrocnemius muscle of the calf is comprised of over a million 
muscle fibers (MacIntosh, Gardiner, & McComas, 2006).  The length of each muscle fiber 
depends on the number of sarcomeres in series that make up the fiber.  The length of the 
longest muscle fiber found in humans is 12 centimeters, so any muscles that are longer than 12 
centimeters are made of series of multiple fibers (MacIntosh, Gardiner, & McComas, 2006).  
 
 
Figure 1:  Human Skeletal Muscle System. Image from anatomyposter.com 
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2.1.1 Structural Hierarchy  
 
Figure 2:  Structural Hierarchy in a Skeletal Muscle 
 
Each muscle fiber, or myofiber, is composed of several nuclei, organelles, a sarcolemma, 
and hundreds of myofibrils.  Surrounding the muscle fiber is the sarcolemma, which consists of 
the basement membrane and plasmalemma.  The plasmalemma is the plasma membrane that 
immediately surrounds the muscle fiber and functions as both an anatomical barrier and a 
selective barrier between the cellular contents and the surrounding connective tissue.  
Anatomically, it separates the aqueous solution containing inorganic ions, sugars, amino acids, 
peptides, and proteins found within the muscle cell from the connective tissue.  The 
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plasmalemma acts as a selective barrier as it contains protein channels and pumps to maintain 
the appropriate protein concentrations inside and outside of the muscle fiber.   
Immediately surrounding the sarcolemma is the basement membrane, composed of the 
basal lamina and the reticular lamina (Sanes, 2003).  The functions of the basement membrane 
involve providing mechanical support to the cells and providing a scaffold for cells during the 
development and regeneration processes.  The basement membrane also has a significant role 
in helping the sarcomere to provide contractile abilities to muscle and in providing elasticity to 
the muscle through the extracellular matrix (Sanes, 2003).  Between the basal lamina and the 
plasmalemma lie the stem cells responsible for muscle regeneration, the satellite cells.  
Myofibrils found within individual myofibers are responsible for producing the motions 
that result in muscle contraction and force production.  Myofibrils are thread-like structures 
aligned along the axial direction of the myofiber, which are mainly characterized by two 
contractile filaments: actin and myosin.  These two proteins are the components of the 
myofibril that are responsible for the elastic and contractile properties of muscles.  Actin and 
myosin filaments are assembled into functional units called sarcomeres, which appear as 
longitudinally repeating banding patterns.  
 17 
 
2.1.2 Sarcomere Structure 
 
Figure 3: Structure of a Sarcomere. Image from shoppingtrolley.net 
The sarcomere itself is characterized by different structures based on the arrangement 
of actin and myosin filaments.  The Z-lines mark the boundaries of each sarcomere and anchor 
the actin filaments at each end.  The A band represents the length of the myosin filaments and 
contains an H zone in its center, which represents the region where there are no actin filaments 
overlapping with myosin filaments.  The I-band represents the region of the sarcomere where 
there are no myosin filaments overlapping with actin filaments.  
This particular arrangement of bands is what gives muscle cells their striated 
appearance.  Besides the aforementioned contractile units, the sarcomere has supporting 
protein structures; titin and nebulin.  Titin is a filamentous protein which is anchored to the Z-
disk at one end, and to the M-line on its other end.  This structural assembly allows anchorage 
of the myosin filaments, which contributes to their structural stability.  Nebulin is another 
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filamentous protein located on the I-band and which provides structural and mechanical 
support to actin filaments (Liu, 2007).  
2.1.3 Extracellular Matrix 
The extracellular matrix of muscle fibers includes both interstitial connective tissues and 
proteins.  There are four main functions of the extracellular matrix: (Liu S. Q., 2007) 
1.  Support and organization of cells, tissues, and organs 
2.  Shape formation of tissues and organs 
3.  Mechanical strength and protection of tissues and organs from injury 
4.  Regulation of cell adhesion, proliferation, migration, and apoptosis 
 
Figure 4:  Muscle Structural Hierarchy Including Connective Tissue 
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2.1.3.1 Interstitial Connective Tissues 
The interstitial connective tissues make up from 1% to 10% of muscle tissue and 
function to support surrounding blood vessels and nerves and to translate the force generated 
within the myofiber into a muscle movement (Schiaffino & Partridge, 2008).  The types of 
connective tissue found in skeletal muscle are the epimysium, perimysium, and endomysium.    
The epismysium is a layer of connective tissue that surrounds the entire muscle, the 
perimysium surrounds a fascicle, or bundle of myofibers, and the endomysium surrounds 
individual myofibers.  
Collagen fibrils, which are abundant in these connective tissues, provide mechanical 
strength to the tissues.  Collagen is characterized by polypeptide chains organized into a triple 
helix structure.  There have been twenty-seven types of collagen identified in vertebrates but 
the three main types of fibrillar collagen are types I, II, and III (MacIntosh, Gardiner, & 
McComas, 2006).  Out of these, collagen type I makes up the majority of interstitial connective 
tissue and tendons.  Collagen type IV is an integral component of the basement membrane and 
binds collagen types I and II in order to securely anchor the interstitial connective tissue to the 
basement membrane (MacIntosh, Gardiner, & McComas, 2006).  
2.1.3.2 Proteins 
 Adhesion of cells to collagen is facilitated by glycoproteins that are found within the 
extracellular matrix.  One glycoprotein that has a role in cell adhesion and migration is 
fibronectin when it is in its insoluble fibrillar form.  On one side, fibronectins bind to cells via 
receptors on the cell membrane matrix known as integrins, and on the other side, fibronectins 
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bind to collagen fibrils.  The binding of collagen and fibronectin to the muscle fiber is the first 
step in the processes of cell adhesion, cell proliferation, and cell migration (Liu S. Q., 2007).  
Another class of glycoproteins is the tenacins, which have a role that counters the 
effects of fibronectin.  Tenacin-C (one of the four members of the tenacin family) is an anti-
adhesive for cells and is also found to increase dramatically in concentration when the muscle is 
bearing a large mechanical load or has been damaged.  Tenacin-X is expressed in high 
concentrations in the extracellular matrix during muscle development, and Tenacin-W and 
Tenacin-R are both involved in re-innervation and neural function relating to skeletal muscle 
(Schiaffino & Partridge, 2008).  
 Integrins also bind to laminins, which are proteins that assemble with collagen type IV to 
form networks within the basement membrane (Schiaffino & Partridge, 2008).  Laminins also 
bind to the dystrophin glycoprotein complex (DGC) which forms a link between the muscle fiber 
and extracellular matrix for transmission of the force produced by sarcomere contraction 
(Schiaffino & Partridge, 2008).    
 Other components of the extracellular matrix include glycosaminoglycans (GAGs).  
Those found in the extracellular matrix of skeletal muscle are heparan sulfates, chondroitin 
sulfates, and dermatan sulfates.  Heparan sulfate is the main GAG found in the basement 
membrane of skeletal muscle and functions as a regulator of muscle development, normal 
function, and regeneration (Schiaffino & Partridge, 2008).  
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2.2 Causes for Skeletal Muscle Loss 
2.2.1 Sarcoma 
Skeletal muscle injury may occur as the result of disease, trauma, ischemia, exposure to 
myotoxic agents or to excessively hot or cold temperatures, and rapid, explosive muscle 
contractions.  One of the major causes of skeletal muscle loss is the removal of 
rhabdomyosarcoma, or a sarcoma of skeletal muscle.  The most common treatment is surgical 
removal of the sarcoma, during which the surgeon must ensure that no cancerous cells remain 
in the area to minimize the possibility of a recurrence.  Since the procedure is highly invasive 
and requires the removal of a significant amount of tissue, patients often require reconstructive 
surgery to rebuild the lost skeletal muscle (National Cancer Institute website, 2007).  
2.2.2 Compartment Syndrome 
Another common cause of skeletal muscle loss is compartment syndrome in which 
swelling or bleeding occurs in a muscle, causing pressure within the muscle and surrounding 
nerves and capillaries to rise to an extreme level.  This pressure buildup impairs the normally 
continuous blood flow to the muscle, so oxygen is unable to reach muscle cells and nerves.  
Acute compartment syndrome, which usually develops as the result of a serious injury such as a 
fracture or a bruise from a severe accident, can often result in permanent tissue death.  
Treatment of acute compartment syndrome usually requires a surgical procedure in which the 
surgeon makes an incision in the skin and fascia of the affected area and closes the skin incision 
once the swelling subsides.  
Chronic compartment syndrome can be caused by overexertion of a muscle, usually by 
an athlete, and can often be relieved by discontinuing the exercise that is causing the swelling.  
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Treatment options include physical therapy and anti-inflammatory drugs.  If the pain and 
swelling does not respond to the non-surgical treatment, surgical intervention is also an option.  
The surgical treatment of chronic compartment syndrome involves the same procedure used 
for acute compartment syndrome, but can often be treated with a smaller incision (American 
Academy of Orthopaedic Surgeons, 2009).  In both forms of the disease, surgical treatment 
leaves an incision which must be repaired for the muscle to become fully functional again.  
2.2.3 Traumatic Injury 
Other major causes of skeletal muscle loss are traumatic injuries, like those seen in 
soldiers injured on the battlefield.  When an injury is too severe for the muscle to fully repair 
itself but not severe enough to require amputation of the limb, the patient will have decreased 
functionality to a degree depending on the severity of the injury.  In injuries involving the loss of 
a relatively small amount of muscle tissue in the elbow or forearm, tissue transfer from another 
area of the body can be performed (Merritt, 2009).  However, this is not a viable solution for 
injuries that involve loss of a greater amount of skeletal muscle since the amount of tissue 
needed for the transplant cannot be removed from another part of the body.  In these larger 
muscle injuries, neither natural repair mechanisms nor tissue transplants are sufficient methods 
for repairing the tissue, so other repair mechanisms must be introduced for functional 
recovery.  
2.3 Process of Skeletal Muscle Regeneration 
The degree of skeletal muscle regeneration is dependent upon the nature of the injury, 
but the process of myofiber repair and regeneration follow relatively the same pathway 
regardless of how the injury arose.  
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 When a large portion of a myofiber’s sarcomere is disrupted, the myofiber becomes 
necrotic.  Two outcomes can follow this scenario.  If blood flow is hindered, fibers will become a 
necrotic mass of non-contractile tissue.  On the other hand, if the blood supply is not 
interrupted, the regeneration process follows the process outlined in three major stages:  
1. Inflammatory response 
2. Activation, proliferation, differentiation, and fusion of satellite cells 
3. Development of myofibers 
(Ciciliot & Schiaffino, 2010) 
 During the inflammatory reaction to necrosis, the plasma membrane breaks down and 
an influx of calcium into the myofiber causes breakdown of the myofibrils (Ciciliot & Schiaffino, 
2010).  This process attracts leukocytes, neutrophils, and macrophages of the immune system 
to the necrotic site (Ciciliot & Schiaffino, 2010).  They remove the debris remaining from the 
breakdown of the myofibrils and are also responsible for secreting anti-inflammatory factors to 
signal the end of the inflammation phase.  This usually occurs between two to four days after 
the initial injury to the muscle (Ciciliot & Schiaffino, 2010). 
The second phase of the regeneration process begins on the second day after injury 
with the activation of satellite cells by various signaling factors.  Satellite cells begin dividing 
mitotically, after which they differentiate into myoblasts and fuse with one another as well as 
with unimpaired segments of the fiber.  It is very important that there is cell-to-cell contact 
between myoblasts since the fusion of myoblasts is dependent on physical proximity of the 
myoblasts.  This fusion causes the differentiation of the myoblasts into myotubes, which are a 
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new source for myonuclei.  Throughout this process, myoblasts also fuse and form 
multinucleated myotubes inside the basal lamina of damaged myofibers.  
This is followed by the production of muscle-specific proteins and maturation of 
myotubes into mature myofibers.  The proliferation and differentiation of satellite cell-derived 
myoblasts occurs rapidly, resulting in the formation of plenty of myotubes in as little as 3 to 4 
days (Brooks and Faulkner, 2003).  During this process, satellite cells are constrained between 
the myofiber and basal lamina.  This helps to prevent migration of the satellite cells away from 
the area of damage and helps to ensure that, once formed, the myofibers produced are 
oriented properly with respect to the existing myofibers (Sanes, 2003).  
There are several factors involved in this myofiber regeneration process, all of which 
together regulate the proliferation, fusion, and differentiation of myoblasts.  The initial injury to 
the muscle promotes the release of growth factors, which bind to ECM proteins.  Two of these 
factors are FGF-2 and HGF, both of which promote proliferation and inhibit differentiation of 
myogenic progenitor cells.  After sufficient time has passed to allow for adequate proliferation 
of myogenic cells, IGF-1 is expressed.  IGF-1 promotes differentiation of myogenic cells and also 
enhances protein synthesis of the differentiated myofiber by activating a translation factor and 
inhibiting protein degradation.  
In the third and final phase of muscle regeneration, the myotubes develop further and 
may become revascularized and reinnervated by blood vessels and nerves, respectively (Ciciliot 
& Schiaffino, 2010).  Ideally, the regenerated myofibers will be oriented in the same fashion as 
the natural myofibers but there is still the possibility that the regenerated tissue will be 
structurally different from the native skeletal muscle tissue since a significant amount of 
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remodeling occurs during the regeneration process (Ciciliot & Schiaffino, 2010).  If the fibers do 
not fuse fully with each other, separate clusters of fibers or forked fibers may form (Ciciliot & 
Schiaffino, 2010).  If satellite cells are able to migrate out of their location between the 
myofiber and basal lamina, individual muscle fibers may form within the interstitial tissue 
(Ciciliot & Schiaffino, 2010).  
Highly severe injuries result in the complete deterioration of the myofiber, leaving only 
the basal lamina in place.  Preserving the integrity of the basal lamina is vital for skeletal muscle 
regeneration as it functions as a scaffold for the formation of new myofibers while minimizing 
fibrosis.  However, in injuries where the basal lamina is heavily damaged, muscle regeneration 
can still take place.  Without a basal lamina to provide support during regeneration, the 
myotubes formed will not be oriented parallel to each other, so the net force produced by 
contraction of the muscle may be insignificant (Sanes, 2003).  
 For the muscle tissue to completely recover function as well as structure, it must be 
reinnervated by axons forming new neuromuscular junctions.  Though the first steps of skeletal 
muscle regeneration can occur without nerve activity, reinnervation has been shown to have 
effects on protein turnover rate, gene expression, and the proliferation and differentiation of 
satellite cells (Schiaffino & Partridge, 2008).  When damage to the skeletal muscle tissue is 
minimal, axons regenerate at the original synaptic site 95% of the time (Sanes, 2003).  The basal 
lamina of the nerve is thought to cause axon regrowth along the same path through connective 
tissue as the original nerve (Sanes, 2003).  
Reinnervation occurs more completely and successfully when the basal lamina of the 
muscle is intact since it provides structural support and plays a role in promoting regeneration 
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(Schiaffino & Partridge, 2008).  The neuromuscular junction and basal lamina are thought to 
take part in promoting the differentiation of a region on the regenerating myofiber into a 
postsynaptic terminal since studies have shown that this process occurs more rapidly during 
regeneration than during normal development (Schiaffino & Partridge, 2008).   
2.3.1 Properties of Native Skeletal Muscle Fiber 
 The properties of a native skeletal muscle fiber that allow for its contractile functionality 
in the body include its elastic modulus, tensile strength, and percent elongation until failure. 
There are mechanical forces provided by bone in vivo that mechanically stimulate the 
developing myofiber to improve these properties (Powell et al., 2002).  When developing a 
system to regenerate skeletal muscle, mechanical stimulation can be applied to the myofiber as 
it is being formed to mimic the naturally occurring process by which the myofiber is 
mechanically stimulated by bone.  
 Studies have been performed to determine the changes in mechanical properties of a 
muscle fiber with and without mechanical conditioning.  In avian and rodent skeletal muscle 
cells, mechanical conditioning involving 3 days of uniaxial stretching and 2-3 weeks of repetitive 
stretching has been shown to improve various properties of the muscle fiber (Powell et al., 
2002).  Mechanical conditioning was found to improve the lengthening, orientation, and 
organization of the myofiber, as well as the composition of the surrounding ECM (Powell et al., 
2002).  In addition to improving the physical properties of the myofiber, mechanical 
conditioning also improves gene regulation, endogenous protein expression, protein 
accumulation, protein localization, and metabolic activity to mimic the processes occurring in 
vivo.  
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 Mechanical conditioning was applied to human skeletal cells with forces approximating 
those found in muscle development in vivo.  Normally, engineered skeletal muscle does not 
reach the diameter of native skeletal muscle, but added mechanical conditioning was found to 
increase the myofiber diameter by 12% (Powell et al., 2002).  Additionally, only 2-15% of 
engineered skeletal muscle is made up of myofibers, as compared to 90% of muscle in vivo.  The 
remainder of the tissue is ECM. The use of mechanical conditioning has been shown to improve 
the percentage of myofibers in engineered skeletal muscle to 40%.  These results could be due 
to the facilitation of enhanced diffusion of nutrients into the core of the tissue by the 
mechanical stimulation.  
 Mechanical conditioning has also been shown to maintain the elastic modulus of the 
myofiber over a period of 8 days of stretching, while non-mechanically conditioned myofibers 
show increased stiffness and elastic modulus over time (Powell et al., 2002).  This stiffening is 
due to collagen cross-linking, which is inhibited by the repetitive mechanical stimulation (Powell 
et al., 2002).  Overall, mechanical stimulation can be used to supplement fiber formation to 
enhance the biological and physical properties of muscle fibers.  These enhancements can be 
used to develop muscle fibers with improved properties and stability than non-mechanically 
conditioned fibers.  
2.4 Clinical Motivation 
 Though muscle is able to regenerate itself naturally, development of a skeletal muscle 
construct similar to natural skeletal muscle in structure and function can be transplanted into 
patients with functional deficits.  Two pathways for achieving this goal are in situ tissue 
engineering, and ex vivo tissue engineering.  In situ tissue engineering involves the targeted 
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introduction of satellite cells to the area of muscle damage.  Ideally, these cells would fuse with 
the existing muscle and improve the functionality of the muscle.  The disadvantage of this 
method is that there is often extensive cell death and typically, only less than 3% of the injected 
cells engraft at the target site (Mooney & Vandenburgh, 2008).  Additionally, the size of the 
area that the transplanted cells can travel from the site of introduction is relatively small, so 
this method is not optimal for large scale regeneration (Mooney & Vandenburgh, 2008).   
Ex vivo tissue engineering involves the development of a functional tissue construct 
using myogenic cells and the implantation of the construct into the site of injury in vivo.  This 
often entails the use of a biological scaffold made of extracellular matrix material and the 
seeding of myogenic cells on the scaffold.  The scaffold serves many purposes as a substrate for 
cells to adhere to, a means to control to the cell localization at the site of damage, and a 
template for the new tissue to form around (Mooney & Vandenburgh, 2008).  The major 
requirements of a scaffold are:  
1.  Biodegradability at a rate that can be controlled  
2.  Biocompatibility throughout the degradation process 
3. Mechanical properties that approximate those of native tissue 
4. Biofunctionality: the ability to support cellular proliferation and differentiation, to 
secrete extracellular matrix , and finally, to form tissue 
(Liu, Ramanath, & Wang, 2008) 
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2.4.1 Current Solutions 
2.4.1.1 Polymer Fibers 
Electrospinning of polymer fibers has been shown to be a viable method for developing 
skeletal muscle constructs.  The process of electrospinning allows for the creation of a complex 
scaffold structure that can accurately direct the migration of cells into an aligned myofiber 
(Aviss, Gough, & Downes, 2010).  The material used by Aviss et al. was a poly(lactide-co-
glycolide) (PGLA) polymer, a biodegradable, elastomeric polymer which degrades into products 
found naturally in the body.  
The architecture of the electrospun fibers was found to be highly effective in the 
creation of aligned myofibers which contain sarcomeres with the banding patterns found in 
native skeletal muscle (Aviss, Gough, & Downes, 2010).  The myofibers were found to 
appropriately support adhesion, proliferation, and differentiation of C2C12 myoblasts and 
when stimulated, were found to contract properly (Aviss, Gough, & Downes, 2010).  The 
disadvantage to this method is the lack of cellular infiltration into the scaffolding material.  The 
use of porous electrospun polymer foams could be more effective in creating a three-
dimensional skeletal tissue construct that more closely resembles native myofibers.  
2.4.1.2 Hydrogels 
 Hydrogels are highly hydrated hydrophilic polymer networks (greater than 30% water by 
weight) that are crosslinked by physical or chemical means.  They can be made of either 
synthetic or biological polymers, but are usually formed from biological materials such as 
collagen or peptide-modified alginate for skeletal muscle regeneration applications (Drury & 
Mooney, 2003).  Since hydrogels are three-dimensional structures, their architecture facilitates 
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cell adhesion, proliferation, and differentiation (Drury & Mooney, 2003).  The major use of 
hydrogels is in the area of highly critical defects in localized areas since they do not have load-
bearing capabilities to regenerate significant amounts of tissue. 
2.4.1.3 Biological Gels 
2.4.1.3.1 Fibrin  
 Fibrin gels have been investigated for use in the development of skeletal myofibers 
because of their three-dimensional architecture and degradability (Huang, Dennis, Larkin, & 
Baar, 2004).  The structure of a fibrin gel allows cells to migrate and proliferate both on the 
surface of, as well as throughout, the fibrin gel matrix (Huang, Dennis, Larkin, & Baar, 2004).  
The fibrin gel matrix degrades within three to four weeks after implantation, by which time the 
cells have produced their own extracellular matrix proteins.  
The experiments conducted by Huang et al. show that by using a fibrin gel matrix, tissue 
constructs formed in ten days, as compared to thirty-six days when cells are left to self-organize 
into fibers (Huang, Dennis, Larkin, & Baar, 2004).  One limitation to this method is that the 
myotubes formed did not grow beyond a diameter of 10 µm, while the diameter of a native 
fiber is around 100 µm.  Additionally, the force produced by the engineered constructs was a 
fraction of the force produced from natural skeletal muscle (36.3 kN/m2 in the engineered 
tissue and 260 kN/m2 in human skeletal muscle). 
2.4.1.3.2 Collagen 
Collagen is used in scaffolds and gels as since they are natural, biodegradable polymers 
that have roles in the formation of the muscle’s framework.  Since it is a protein that is found in 
the connective tissue of native ECM, it is involved in biological processes such as cell 
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attachment and tissue regeneration (Grant et al., 2001).  These properties of collagen make it a 
potential candidate for a gel matrix with the capability to support and enhance skeletal muscle 
regeneration.   
2.4.1.3.3 Matrigel™ 
Matrigel™ is an extract of extracellular matrix formed from Engelbreth-Holm-Swarm 
(EHS) tumor in mice that contains components of the extracellular matrix of the basement 
membrane.  These components include type IV collagen, regularly arrayed sulfated 
macromolecules, and a high content of glycosylated molecules (Kleinman and Martin, 2005). 
Matrigel™ has been shown to promote cell morphogenesis and differentiation (Kleinman and 
Martin, 2005).  
 Studies of the mechanics of myogenic cell proliferation and differentiation have shown 
significant differences between the differentiation of C2C12 cells with and without use of a 
Matrigel™ coating to the plate.  Results have shown that there is enhanced differentiation and 
reduced proliferation when Matrigel™ is used as a coating (Kleinman and Martin, 2005). 
Additionally, the use of a Matrigel™ coating has been shown to enhance the rate of myotube 
formation and the alignment of the myotubes into an organized axial pattern (Kleinman and 
Martin, 2005).  Therefore, the addition of Matrigel™ to either a collagen or fibrin gel can 
provide the cells with the advantages of the gel, in addition to the capabilities of the Matrigel™ 
including differentiation, rapid myotube formation, and alignment.   
2.4.1.4 Extracellular Matrix Threads 
Braided collagen threads can be used as scaffolds since collagen is biodegradable and 
biocompatible, and since the architecture of the braided system provides a large surface area 
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for cell migration (Makridakis, Pins, Dominko, & Page, 2009).  In experiments conducted by 
Makridakis et al., the collagen threads were chemically crosslinked and results after one day of 
culturing of muscle derived fibroblastic cells showed significant cell attachment.  The use of 
braided collagen threads as scaffolds is a promising area of research but still poses some 
limitations.  Since the cells are only able to migrate and proliferate on the surface of each 
individual thread, the system may not be able to produce a fiber that is structurally analogous 
to a native muscle fiber.  
2.4.1.5 Current Molding Systems 
 There are some molding systems that are currently used to produce muscle fibers.  
Many of these systems rely on a substrate, usually made of ECM components, for the cells to 
proliferate and differentiate on top of.  However, these extra components that act as substrates 
often add an extra level of complexity to the molding system that could be eliminated with the 
introduction of a molding system that relies mainly on the architecture of the mold for proper 
fiber formation and alignment.  
 In a study conducted by Lam, Huang, Birla, and Takayama, a laminin substrate was used 
to coat a wavy micropatterned PDMS mold (Lam et al., 2009).  Myoblasts were seeded on top 
of the laminin layer and once the plate was 80-90% coated in myotubes, fibrin gel was added 
on top of the cell layer (Lam et al., 2009).  Acting as a provisional matrix, the fibrin gel caused 
the myotube layer to detach from the laminin substrate and wrap around the gel (Lam et al., 
2009).  As differentiation proceeded, the cells degraded the fibrin and produced their own ECM 
components (Lam et al., 2009).  
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Figure 5: Representation of Fibrin Gel, Myoblasts, and Laminin Substrate Model (Lam et al., 2009) 
 In another study, a silicone on insulator (SOI) wafer was micropatterned with cantilevers 
and the culture surface of the silicone was coated with a diethylenetriamine (DETA) substrate 
(Das et al., 2006).  DETA is a synthetic, non-biological material which has, in other studies, 
proved to be an appropriate surface for neuron and endothelial cell growth due to its cell 
attachment properties that result from its hydrophilicity and presence of amine groups (Das et 
al., 2006).  The cells were then cultured onto the DETA substrate and myofibers conforming to 
the cantilever shape were formed.  
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Figure 6: Cantilever Molding System (Das et al., 2006) 
 In each of the previous molding systems mentioned, the growth of the myofiber is 
dependent on the presence of the substrate, whether it is a biological material like laminin or a 
synthetic material like DETA.  The development of a molding system that does not involve the 
coating of a substrate on the mold will represent a simplified system that requires only the 
presence of cells, a mold containing anchor points, and if necessary, a provisional matrix made 
of a biological material. 
2.5 Cell Lines used for Study of Muscle Regeneration 
The cell line that is often used to study muscle regeneration is the C2C12 mouse 
myoblast line.  The C2C12 cell line differentiates rapidly and is able to form myotubes with 
contractile abilities and producing the proteins found in muscle tissue (Blau et al., 1985). 
(Product Description , 2010).  They can be used in a variety of applications such as the 
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development of myofibers as in vitro models of skeletal muscle formation and function to 
represent the parallel processes in the body.  
2.5.1 Medium Components for Myogenic Cells 
There are several components that can be added to standard culture medium 
formulations to enhance specific functions of myogenic cells.  These enhancement factors can 
increase cell proliferation, increase myoblast differentiation, or promote dedifferentiation into 
progenitor cells.  Table 1 contains descriptions of some medium enhancing factors that can be 
used to promote certain types of cellular behavior.  
Table 1: Medium Enhancing Factors 
Enhancing Factor Outcome 
Insulin Promote myoblast differentiation and fusion (Ewton and 
Florini., 1981). 
TGF-β1 Triggers dedifferentiation of myoblasts/generates progenitor 
cells (Musgrave et al., 2001). 
Sodium Ascorbate Decreases the material stiffness and increases the tensile 
strength of tissue construct.  Increases cell proliferation. 
(Camozzi et al., 2006) 
Serum-free medium Increases the extent of cell differentiation (Karger 2000). 
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Chapter 3: Project Strategy 
The ultimate goal of this project was to design a molding system that recapitulates 
skeletal muscle fiber structure and into which myogenic cells can be seeded such that skeletal 
muscle tissue is formed.  In order to attain this goal, it will be necessary to use a gel matrix to 
create a three dimensional structure and a scaffold-free molding system for the proper 
formation of a structurally-accurate skeletal muscle fiber.  These two requirements of 
developing a 3-D structure and forming a muscle fiber of the proper structure must be met in 
order to achieve the final goal.  The purpose of this chapter is to explain the step-by-step design 
process the group underwent to determine objectives for the project and to weigh the each of 
the project objectives.  The chapter conclusion will provide an overview of the group’s 
approach to solving the design problem and the methods by which to fulfill the objectives and 
meet the client statement.   
3.1 Design 
In general, the design process allows the designer to break a complex system down into 
specific parts and offers tools that will help determine the most cost-effective and optimized 
product that will satisfy the client.  The design process is important in creating a product as it 
allows the design team to make logical, unbiased decisions in discussions and decisions about 
product details.  This section describes the steps the group took in the design process to revise 
the initial client statement, decide on project objectives, functions, and constraints, and finally 
to prioritize each of the objectives.  Ultimately, the design process provided the tools for the 
group to create a prototype of a molding device that can recapitulate human skeletal muscle 
fiber. 
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 A precursor to the design process is the identification of the stakeholders of the 
product.  The stakeholders for this project are the designers of the product, the users of the 
product, and most importantly, the client who initially expressed the need to create the 
product.  For this project, the client is Professor Raymond Page.  He provided the group with an 
initial client statement that described the current techniques of creating muscle fibers, why 
there is a need for the product we were tasked to develop, and what deliverables were 
expected from the designers at each project milestone.  The potential users of this product will 
be the graduate students and researchers at WPI whose research involves muscle regeneration.  
The design team, made up of Sahil Bhagat, Carlos Donado, and Deepti Kalluri, aimed to 
understand the needs and wants of both the client and the users and to create a product that is 
feasible and will satisfy all parties.  
3.2 Initial Client Statement 
The next step is to identify the goals of the project and to clarify them in order to 
understand exactly what the stakeholders want the product to accomplish.  Our initial client 
statement from Professor Page was: 
“Biopolymer micro-threads produced from materials such as fibrin and collagen have 
proven useful as scaffolds to seed anchorage dependent cells to facilitate formation of 
tissue with linear structure.  These materials are also useful for in vivo applications where 
the scaffold material must be degraded and replaced with new extracellular matrix 
produced from the transplanted cells.  This approach is particularly useful for formation 
of skeletal muscle for both modeling skeletal muscle tissue formation in vitro and 
delivering cells to replace lost or damaged skeletal muscle in vivo.  Currently, the micro-
threads are produced first and then cells with myogenic potential are seeded onto the 
micro-threads using a rotational cell seeding system.  The limitations of this system 
include the ability to only achieve a cell density limited to the surface area of the micro-
threads.  For cylindrical tissue such as skeletal muscle fibers to form, the cells must 
degrade the micro-thread material and proliferate and migrate into the core.  The 
proliferation phase of the cell cycle is not compatible with the quiescent phase required 
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for cell fusion and matrix synthesis needed for skeletal muscle tissue formation.  This 
could to lead to premature breakdown of the tissue structure before the seeded cells can 
synthesize new matrix.  An optimal situation would involve a system where cells could be 
seeded at the density required for cell fusion and tissue formation.  However, the current 
micro-thread production process involves a stretching and drying step to produce axially 
aligned fibers, which is not compatible with seeding the cells within the micro-threads at 
the time of formation.  The goal of this project is to design a molding system that 
recapitulates skeletal muscle fiber structure into which myogenic cells can be seeded 
such that skeletal muscle tissue is formed.  The system must be either produced 
aseptically or must be sterilizable and fit into an incubator in order to permit study of live 
cells over time.  The size of fibers produced by the mold should approximate those of 
native skeletal muscle and must strong enough to permit handling for implantation 
(similar to micro-threads produced currently).  The fibers produced must be able to be 
anchored to prevent tissue collapse and ideally will be made such that mechanical stretch 
can be applied to mechanically condition the newly formed muscle tissue.”   
As a design team, it is important to understand all parts of the client statement, but for 
simplicity, the client statement must be distilled down to a few sentences that express the 
objectives and constraints of the project.  The group accomplished this task by asking the client, 
Professor Page, numerous questions during weekly meetings in order to clarify exactly what the 
final product is supposed to accomplish.  After the client meeting, the design team had a group 
meeting where the new ideas were discussed and design ideas for the molding system which 
incorporated the information from the client meeting were brainstormed.  
3.3 Objectives, Constraints, and Functions 
Once the design goals are clarified, it is necessary to separate the goals into objectives 
and constraints.  The next step is to list some possible functions that will allow a product to 
meet those objectives and constraints.  The difference between objectives, constraints, and 
functions is that objectives are the tasks that the product should be able to perform in order to 
satisfy the client and the users and to be considered a successful product, constraints are 
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specific conditions the product design must meet in order to be functional, and functions are 
the means by which the objectives and constraints will be achieved.  
Objectives:  
1. Develop a molding system of defined dimensions suitable for in vitro analysis of 
mechanical properties which allows formation of skeletal muscle fibers in vitro using 
skeletal muscle myoblasts 
2. Determine the composition of a provisional ECM to be used during seeding that will 
structurally support the overall tissue architecture until the myoblasts differentiate and 
fuse to form multinucleated myotubes and muscle fibers 
3. Produce fibers that approximate the diameter of native skeletal muscle 
4. Produce fibers that are strong enough to handle during in vitro testing of mechanical 
strength and contractile force, and ultimately, implantation into skeletal muscle wound 
models 
5. Anchor fibers in place to prevent tissue collapse during formation or following 
differentiation 
6. Allow for mechanical stretch that can be applied to mechanically condition newly 
formed muscle tissue 
7. Allow for electrical stimulation to assess contractile function. 
 
Constraints:  
 Must fit within an incubator 
 Sterilizable with on-site resources (Autoclave, ethylene oxide, alcohol bath) 
 Materials must be commercially available or easily manufactured using campus or 
collaborator resources 
 System must be easy to monitor and maintain (keep sterile while changing culture 
medium) 
 Materials must not be cytotoxic  
 Individual fiber diameter should close to that of native skeletal muscle  (~100 µm)  
 $368 Budget 
 
Functions of the Molding System: 
 Able to seed cells in a spatially controlled manner and at a specific cell density 
 Able to perform viability assays 
 Able to confirm effectiveness of provisional ECM on cell differentiation and 
maintenance of overall tissue integrity  
 Able to secure tissue during formation to prevent collapse  
 Able to mechanically condition the fiber 
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 Able to manipulate the formed tissue for testing for mechanical strength and 
electrically stimulated contractile force 
 Able to control fiber properties (fiber diameter and length)  
 
3.3.1 Pruned Objectives 
After creating a general and comprehensive list of objectives, the design team created a 
pruned objective list based on meetings with the client and the design team’s brainstorming 
sessions.  Some objectives were deleted while others were combined. Each final objective was 
broken into sub-objectives that need to be fulfilled in order for the main objective to be 
completed successfully.  The list below is the final pruned objective list following numerous 
revisions.  
Objectives:  
1. Find the optimal cell density to form muscle fiber 
A. Consistent Cell Seeding 
B. Composition of provisional ECM to support tissue structural integrity while 
myoblasts are differentiating to form myotubes 
C. Define differentiation conditions to ensure myoblasts are not proliferating while 
tissue is being formed 
D. Appropriate culture medium to support cell fusion and tissue formation 
 
2. Produce strong fibers that approximate native skeletal muscle  
A. Structural fiber integrity and uniform alignment along the axis of tissue forming 
mold  
B. Uniform fiber dimensions 
C. Fiber stability/viability (over 10 – 14 days)  
D. Consistent fiber dimensions (batch to batch)  
 
3. Anchor fibers in place 
A. Consistent initial position of anchors 
B. Consistent distance increase of the anchors at a determined frequency and 
magnitude 
C. Strong fiber attachment to anchor points 
D. Allow for electrical stimulation, mechanical stretch, and 
observation/measurement of contractile function  
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4. User –friendly 
A. Easy to use (Integrated system and minimum components) 
B. Easy to clean for reuse 
C. Safe 
 
5. Time-efficient  
A. Takes less time than current standard using micro-threads  
 
6. Cost-effective 
 
The list above shows the design team’s six main objectives:  
1. Finding an optimal cell density to form human skeletal muscle fiber 
2. Producing strong fibers that have similar cross sectional dimensions to those of native 
human skeletal muscle 
3. Anchoring muscle fibers in place 
4. Developing a product that is time-efficient 
5. Developing a product that is cost-effective  
6. Developing a product that is user-friendly  
 
The optimal cell density needed to form skeletal muscle tissue is the one that allows 
adequate intercellular contact so the cells can align and fuse into multinucleate myotubes. 
Thus, the cells need to be previously amplified in proliferative culture conditions in the 
undifferentiated state to generate numbers required for seeding into the molding system using 
culture conditions to promote differentiation.  Finally, the mold/seeding system should 
facilitate cell fusion and myotube alignment in the axial direction. 
To complete the second objective of producing strong fibers that are similar to native 
human skeletal muscle, the design team would need to ensure that when the fiber is initially 
formed, it is strong enough to be moved and stretched.  Fiber strength and integrity is 
important because the fiber should be strong enough to be moved during transplantation 
procedures and stretchable to allow for mechanical conditioning.  Furthermore, the fiber 
should be uniform in diameter throughout its length and the molding device should produce 
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fibers of the same dimensions during each use of the molding system.  Lastly, the muscle fiber 
should be able to maintain its mechanical properties long enough to be conditioned and be 
implanted into an animal model.  
The design team had to determine a way to anchor the newly formed fiber in a way such 
that the fiber will be anchored in the same place every time in order to be consistent with every 
use of the molding system.  In order to stretch the fiber for mechanical stimulation, the 
increase in distance between the anchor points for stretching should also be consistent each 
time to stimulate fiber formation in the same direction and in the same manner.  The anchor 
points are also important for structural integrity since they keep the fiber taut and prevent its 
collapse.  The molding system must also be produced in the most economical way possible 
while still fulfilling all the other objectives.  Additionally, the device should be easy to use and 
should allow the user to develop muscle fibers in a timely fashion.   
 
3.3.2 Quantitative Analysis of Objectives 
The designing of a device involves the process of optimizing a device to perform 
specified functions safely and in a cost and time effective manner that will satisfy the client’s 
needs.  It is impossible to fulfill each objective with the best solution, as that solution might 
conflict with another objective.  Thus, in order to produce the best possible product, it was 
necessary to weigh and prioritize the objectives.  
This was done by creating pairwise comparison charts.  Since the client, Professor Page, 
and the design team are the stakeholders, each of them has equal weight in their pairwise 
comparison of the objectives. In a pairwise comparison, the objectives in the same tier, such as 
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the main objectives and the sub objectives under each main objective, are compared against 
each other.  
Each two objectives were compared at the same time and the objective determined to 
be more important receives a score of 1 while the objective determined to be less important 
receives a zero.  If both the objectives are determined to be of the same importance, a score of 
0.5 is given to each of the objectives.  The scores need to be normalized by adding a 1 to the 
aggregated score in order to ensure a non-zero value for all objectives.  Finally, a weight is 
created for each objective to allow a reader to quickly understand which objectives were found 
to be the most important and by what percentage.   Table 2 shows the results of the pairwise 
comparison of the main objectives.  For each objective, the client’s score is on the left column 
while the design team’s is on the right.  
Table 2: Pairwise Comparison Table of Main Objectives 
Main Objectives 1 2 3 4 5 6 Aggreg. 
Score 
Normalized 
Score 
Weight 
1. Find optimal cell density   0.5 0.5 0.5 0.5 1.0 1.0 0.5 1.0 0.5 1.0 7.0 8.0 .229 
2. Fiber similar to native muscle 0.5 0.5   0.5 0.5 1.0 1.0 0.5 1.0 0.5 1.0 7.0 8.0 .229 
3.  Anchor fiber in place 0.5 0.5 0.5 0.5   1.0 1.0 0.5 1.0 0.5 1.0 7.0 8.0 .229 
4. Time efficient 0.0 0.0 0.0 0.0 0.0 0.0   0.0 0.0 0.5 0.0 0.5 1.5 .043 
5. Cost effective 0.5 0.0 0.5 0.0 0.5 0.0 1.0 1.0   0.5 1.0 5.0 6.0 .171 
6. User-friendly 0.5 0.0 0.5 0.0 0.5 0.0 0.5 1.0 0.5 0.0   3.5 3.5 .100 
 
The pairwise comparison chart above shows that while all the main objectives are 
important, certain objectives are more important than others.  The three most important 
objectives, according to both of the stakeholders, are finding the optimal cell density, producing 
a fiber that is similar to native human skeletal muscle fiber and being able to anchor the fiber in 
place. Following those three objectives in importance are having a device that is as cheap as 
possible to produce and use, a device that is user-friendly, and a device that is simple enough 
 44 
 
that it does not take a long time to set up and use.  Table 3 is a comparison of the sub-
objectives of the first main objective. 
Table 3: Pairwise Comparison Table of Sub-Objectives I 
1. Find optimal cell density A B C D Aggregated 
Score 
Normalized 
Score 
Weight 
A. Consistent Cell Seeding   0.0 0.0 0.0 0.5 0.0 0.5 1.0 2.0 .125 
B. Strong ECM 1.0 1.0   0.5 0.5 0.5 0.5 4.0 5.0 .313 
C. Proliferate/Differentiate 1.0 0.5 0.5 0.5   0.5 0.5 3.5 4.5 .281 
D. Cell Fusion/ Tissue formation 1.0 0.5 0.5 0.5 0.5 0.5   3.5 4.5 .281 
 
Within the major objective of finding optimal cell density, it was established by client 
and the design team that having a strong ECM was the most important sub-objective.  It was 
followed closely by ensuring that proliferation and differentiation are occurring at the 
appropriate times, and having the proper culture medium for cell fusion and tissue formation.  
Ensuring that there is consistent cell seeding during each use of the molding system was 
considered to be the least important sub-objective.  
Table 4: Pairwise Comparison Table of Sub-Objectives II 
2.Fiber similar to native muscle A B C D Aggregated 
Score 
Normalized 
Score 
Weight 
A. Fiber Integrity   0.5 1.0 0.5 0.5 1.0 1.0 4.5 5.5 .344 
B. Uniform Fiber 0.5 0.0   0.5 0.0 1.0 1.0 3.0 4.0 .250 
C. Fiber Stability 0.5 0.5 0.5 1.0   1.0 1.0 4.5 5.5 .344 
D. Consistent Fiber (Batch to Batch) 0.0 0.0 0.0 0.0 0.0 0.0   0.0 1.0 .063 
 
The stakeholders decided that, with respect to the main objective: having a fiber similar 
to native muscle, developing a fiber with continuous integrity, and developing a fiber with long-
term stability were tied for the most important sub-objectives.  The development of a uniform 
fiber was the next most important sub-objective, while producing consistent fibers from batch-
to-batch was considered the least important sub-objective.  
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Table 5: Pairwise Comparison Table of Sub-Objectives III 
3. Anchor fibers in place A B C D Aggregated 
Score 
Normalized 
Score 
Weight 
A. Consistent initial position   1.0 0.5 0.5 0.0 1.0 0.0 2.0 3.0 .200 
B. Consistent distance increase 0.0 0.5   0.0 0.0 0.0 0.0 0.5 1.5 .100 
C. Prevent fiber collapse 0.5 1.0 1.0 1.0   1.0 1.0 5.5 6.5 .433 
D. Allow for Elec. Stimulation 0.0 1.0 1.0 1.0 0.0 0.0   3.0 4.0 .267 
 
 The most important sub-objectives under objective for anchoring fibers in place were 
that the device should prevent the fiber from collapsing and allow for electrical stimulation.  
Furthermore, the device should facilitate the placement of a consistent initial position of the 
fiber’s anchors.  Consistent distance increase of the anchors in order to stretch the fiber would 
be desirable but it was found to be a fairly low-priority sub-objective.  
Table 6: Pairwise Comparison Table of Sub-objectives IV 
4. User-friendly A B C Aggregated 
Score 
Normalized 
Score 
Weight 
A. Ease of use   0.5 0.0 1.0 1.0 2.5 3.5 .389 
B. Safe 0.5 1.0   1.0 1.0 3.5 4.5 .500 
C. Easy to clean 0.0 0.0 0.0 0.0   0 1.0 .111 
 
Last but not least, under the main objective of User Friendly, user safety was the highest 
weighted sub-objective.  The second highest-ranked sub-objective in this comparison was ease 
of use. Easy to clean was ranked the least important of the three sub-objectives.  
After completing the pairwise comparison tables, each of the sub-objectives were 
weighted together.  This exercise allowed the design team to understand which sub-objectives 
required more focus for the development of a successful device.  To summarize the results, a 
weighted objectives tree, as seen in Figure 7, was created.  Within the weighted objective tree, 
the number on the left is the weight of the objective within its branch.  The number on the right 
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is the weight of the objective when compared to all the objectives in the whole tree.  A more 
simplified version of the weighted objective tree is shown in Figure 8 as a bar graph. 
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Figure 7:  Weighted Objective Tree 
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Figure 8: Summary of Weighted Objective Tree 
3.4 Revised Client Statement 
After meeting with the client and user, brainstorming several ideas, and conducting 
analysis of the objectives using pairwise comparison tables, the original client statement was 
revised.  The revised client statement is:   
Design a sterilizable molding device where myogenic cells can be seeded to recapitulate 
native skeletal muscle fiber which can be anchored to prevent tissue collapse and can be 
mechanically conditioned.   
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3.5 Project Approach 
The group developed a two-step approach to represent the process by which myogenic 
cells are seeded into a gel, the cell-gel solution is placed within a mold, and differentiation is 
promoted by a switch to differentiation medium.  This process is represented in Figure 9.  
 
Figure 9: Schematic of Project Approach for the Seeding of a Cell-Gel Solution into a Mold 
The main aims that must be achieved for this approach to be effective are to:  
1) Provide a gel matrix for the cells to proliferate within 
There are several advantages to using a gel as a provisional matrix for the cells. 
The use of a gel matrix allows for a 3-D structural geometry that represents that of a 
native muscle fiber.  Though the gel is initially in a liquid form, its polymerization causes 
it to transition into a more solid state.  The polymerized gel forms a 3-D structure, while 
conforming to the space that it is placed in.  When the cells are within this gel matrix, 
they will have the advantage of taking the shape provided by the gel.  Additionally, since 
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the gel is often made of biological materials such as collagen or fibrin, the biological 
cues provided by the gel to the cells stimulate their proliferation and differentiation into 
myofibers.  Over time, the biological gel will be degraded by the cells and the cells will 
form their own ECM, while maintaining their initial structure.  
2) Provide a constrained seeding channel for the cells to conform to 
The use of a seeding channel within which to seed the cell-gel solution allows for 
the development of a muscle fiber into a desired shape.  For example, a seeding channel 
with a rounded bottom will lead to the creation of a cylindrical cell-matrix structure.  A 
long seeding channel with a length approximating that of a native skeletal muscle fiber 
can be used to create muscle fiber of the same length.  
3) Provide anchor points for the cells to pull on and align themselves  
Anchor points within the molding system will act as points around which cells 
can attach.  Cell congruity at these anchor points will lead to a cohesive network of cells 
that will pull on each other from each anchor point, promoting uniaxial alignment of the 
cells.  The pulling from each anchor point will also prevent tissue collapse, as there will 
be tension throughout the length of the fiber.  
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Chapter 4: Alternative Designs 
The team held a brainstorming session to develop alternatives designs.  Five design 
alternatives for the molding system were generated. Each of these five alternatives was 
evaluated and an illustration and pros and cons of each design are outlined below. 
4.1 Needs Analysis 
After several brainstorming sessions and client meetings, it was determined that the 
molding system to be designed must form a skeletal muscle fiber that is similar in morphology, 
contractile properties, and mechanical properties to a native human skeletal muscle fiber.  This 
requirement is important because a muscle fiber without the proper morphology will not 
integrate properly with native muscle in the tissue recipient.  Also, a muscle fiber without 
similar contractile and mechanical properties will not react properly to neural signals or 
contract with the magnitude necessary for functionality.  The molding system also needs to 
produce a skeletal fiber that is at least 1 centimeter long.  There is a minimum fiber length 
requirement because any mechanical testing on any fiber that is shorter than 1 centimeter 
would be difficult.   
If possible, it would be desirable for the molding system to allow for mechanical 
stimulation of the skeletal muscle fiber.  Previous studies have shown that mechanically-
stimulated muscle fibers have better mechanical properties than non-stimulated muscle fibers. 
In the future,  if the muscle fibers are properly formed, they would be used for in vivo testing 
where they would be implanted into mice.  Thus, it would also be desirable to design the 
molding system with a method of easy removal of the fiber.  Also, due to economical and 
manufacturing constraints, the molding system currently being designed will not be able to 
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produce a muscle fiber that is close to the size of a native muscle fiber.  However, it is desirable, 
when the affordable manufacturing capabilities exist, to machine a molding system that can 
produce a human skeletal muscle fiber with a diameter of 100 μm. 
4.2 Conceptual Designs 
4.2.1 Circumferential Molding System: 
The use of a molding system to grow tissue rings was adapted from the Rolle Lab at WPI. 
An acrylic mold is machined with annular wells containing inner posts with a diameter of 1 
millimeter.  The annular wells are positioned both vertically and horizontally next to each other, 
separated by the same distance.  A mixture of Polydimethylsiloxane (PDMS) and curing agent 
(10:1 ratio of PDMS to curing agent) is poured onto the acrylic mold to create a negative 
template. A solution of agarose mixed with Dulbecco’s Modified Eagle Medium (DMEM) is then 
poured onto the PDMS negative to cast annular agarose wells, which would be removed from 
the negative and placed in 6-well plates.  
C2C12 cells are seeded into each well at a concentration of 1.5 million cells per well kept 
at 60 percent confluency.  The cells, at this stage, are cultured in proliferative media made of 
DMEM, F12, FBS, glutamine, penicillin/streptomycin, and insulin (Lluri and Jaworski, 2005). 
After proliferating for two days and reaching 100 percent confluency, the proliferation media 
will be replaced with differentiation media made of DMEM and F12, and supplemented by 
Insulin- Transferrin- Selenium (ITS), glutamine, and horse serum (Lluri and Jaworski, 2005). 
Once the rings form, each ring is cleaved at one specific point, resulting in one myofiber per 
well, each with dimensions approaching those of skeletal muscle (100 microns in diameter, and 
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4 millimeters in length).  At this point, they are they are prepared for histological analysis and 
mechanical testing.  
 
Figure 10: Individual well in the Circumferential Molding System 
Pros:   
 Batch uniformity 
 Control over fiber dimensions 
Cons: 
 Difficult to stretch for axial alignment 
  Non-uniformity of tissue construct due to circular shape 
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4.2.2 Dog Bone System: 
An acrylic mold is created by machining two cylindrical posts, each with a diameter of 5 
mm on a base made of acrylic.  Each post is separated horizontally from the other by a distance 
of 12 mm. A mixture of Polydimethylsiloxane (PDMS) and curing agent (10:1 ratio of PDMS to 
curing agent) is poured onto the acrylic mold to create a template, after which a solution of 
agarose mixed with DMEM is poured onto the PDMS negative to cast a mold of the same 
structure as the original acrylic mold.  The mold itself is in a “dog bone” shape with the two 
posts located in the circular portions of the mold.  The edges of the mold are raised to create a 
well within the structure and the two posts are raised above the level of the surface to serve as 
anchor points for the cells seeded within the well.  
C2C12 cells are seeded into the well at a concentration of 1.5 million cells per well kept 
at 70 percent confluency.  Cells are cultured in proliferative media made of DMEM, F12, FBS, 
glutamine, and penicillin/streptomycin are incubated at a temperature of 37° C for two days 
(Lee et al., 2007).  After that, the cells reach 100 percent confluency and the proliferation media 
will be replaced with differentiation media made of DMEM, F12, ITS, glutamine, and horse 
serum.  Once the tissue forms around the posts, it will go through histological analysis and 
mechanical testing. 
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Figure 11: Individual Cell Seeding Channel in the “Dog Bone” Molding System 
Pros: 
 Ability to anchor cells 
 Batch uniformity 
 Control over fiber dimensions 
 Uniformity of tissue construct 
Cons: 
 Mechanical properties are not completely uniform throughout fibers 
4.2.3 Micro-thread Extrusion System: 
4.2.3.1 Fibrin micro-threads 
A fibrin micro-thread co-extrusion system was adapted from the Pins Lab.  Fibrinogen 
and thrombin from bovine plasma are placed in separate syringes, and are coextruded using a 
stabilized crosshead on a threaded rod through a blending connector in which both solutions 
are mixed and extruded through polyethylene tubing.  The resulting fibrin micro-threads are 
released into a buffered bath (HEPES, pH 7.4 at room temperature) and after 15 minutes, they 
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are removed from the bath to be air-dried overnight, and finally stored in a desiccator at room 
temperature.  
 
Figure 12: Co-extrusion System for Fibrin Micro-threads (Cornwell and Pins, 2006) 
 
4.2.3.2 Collagen micro-threads: 
As a first step, acid soluble type I collagen is extracted from rat tails.  Collagen threads 
are extruded either from solutions of insoluble or soluble type I collagen.  Collagen solution is 
stored in a syringe and is extruded through polyethylene tubing by using a syringe pump set at 
a certain flow rate.  Threads are released into a bath and maintained initially in fiber formation 
buffer overnight, followed by fiber incubation buffer for 24 hours and lastly by distilled water 
for another 24 hours.  Finally, the threads are removed from the water bath and stored in a 
desicator at room temperature. 
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Figure 13: Extrusion System for Collagen Micro-threads 
In the next step, micro-threads are placed on a reflective aluminum foil surface and 
cross-linked by exposing the micro-threads to UV radiation emitted from an ultraviolet 
crosslinker for a certain period of time.  This is done with the aim of increasing the strength and 
stiffness of the threads. 
Bundles of 10 micro-threads are then placed on 35 mm culture dishes by gluing them 
onto coverslips supplemented by silicone adhesive.  Each thread is seeded with 100 µl of cells in 
medium and incubated with 10% FBS for 30 minutes.  After the incubation period, thread 
bundles are released from coverslips and cell proliferation and attachment, and mechanical 
properties are analyzed.   
Pros:  
 Enhanced rate of cell migration 
 Provides some structural alignment for cells 
Cons: 
 Inconsistencies in scaffold preparation 
 Possibility of insufficient cell migration into the thread’s core 
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4.2.4 Series Molding System 
An acrylic mold is created by machining several elongated posts on an acrylic base.  Each 
post is separated longitudinally from neighboring posts by 100 µm.  A mixture of 
Polydimethylsiloxane (PDMS) and curing agent (10:1 ratio of PDMS to curing agent) is poured 
onto the acrylic mold to create a template, after which a solution of agarose mixed with DMEM 
is poured onto the PDMS negative to cast a mold of the same structure as the original acrylic 
mold.  The mold has a series of elongated posts which are separated longitudinally from the 
neighboring elongated posts by 100 µm.  Above and below each elongated post would be an 
oval shaped post, to serve as anchor points for the fibers forming around the elongated posts.  
C2C12 cells are seeded into the molding system at a concentration of 6 million cells per 
molding system, kept at 70 percent confluency.  Cells are cultured in proliferative media, and 
are incubated at a temperature of 37 °C for two to three days, after which the proliferation 
medium is removed and replaced with differentiation medium.  Once the tissue forms around 
the posts, it will go through histological analysis and mechanical testing. 
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Figure 14: Cell Seeding System for the Series Molding System 
Pros:  
 Control over fiber dimensions 
 Ability to anchor cells 
Cons: 
 Mechanical properties are not completely uniform throughout fibers 
 
 
 
100 µm 
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4.2.5 Pin and Mesh Molding System 
In the pin and mesh molding system, a base made of acrylic is machined such that there 
are semi-circular channels running parallel to each other.  The anchoring system within the 
model consists of a silk thread, either end of which is tied around each of two minutien pins. 
The silk thread is tied at the midpoint of the minutien pin so that it is suspended at about the 
middle of the tubular structure.  The final component is a mesh-like structure made of a 
biocompatible metal such as titanium, which is placed on top of the system.  
C2C12 cells, suspended within a gel matrix, are seeded into the tubular structures.  The 
minutien pins, connected by the silk thread, are then placed along the length of the tube, and 
the metal mesh is placed on top of the PDMS mold.  The metal mesh provides structural 
support to the gel, so that it forms a cylindrical structure, while still allowing oxygen diffusion to 
the cells through the holes within the mesh.  
 
 
Figure 15: Cell Seeding in a Pin & Mesh Model 
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Pros:  
 Control over fiber dimensions 
 Provides structural alignment to cells 
 Ability to anchor cells 
 
Cons: 
 Mechanical properties are not completely uniform throughout fibers 
 Large number of components and complexity of device 
 
The team performed a qualitative analysis on the design alternatives to determine the 
final design.  The final design chosen by the design team was the dog-bone molding system. The 
reason was because out of the five total designs, the dog-bone molding system fulfilled all 
constraints and reached the largest number of the specified goals and objectives.  
After the design team met with the client, the client mentioned that it would be 
preferable for the recapitulation of the muscle fiber to occur without the aid of a scaffold.  
Hence, the Microthreads system was removed for further consideration.  
The Circumferential molding design was not chosen because producing a skeletal 
muscle fiber, which is usually linear, in a circular shape could potentially cause fiber formation 
and integrity issues.  Slight non-uniform seeding could cause the cells in the highest density to 
start pulling on the cells adjacent to them.  This cell aggregation could prevent many cells from 
receiving oxygen and nutrients and could cause the cells to die.  Even if uniform cell seeding 
occurred and a fiber formed, there would be the possibility of the contracting force of the fiber 
causing it to break.  Additionally, due to its circular shape and lack of points from which to 
perform mechanical conditioning of the tissue, the circumferential molding system is not 
amenable to mechanical conditioning.  
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The Series molding system could potentially produce muscle fibers at sizes very close to 
native muscle fiber, however the problem with the molding system is that it must be 
manufactured by photolithography, which is cost prohibitive with the current budget.  
Through discussions with the client, the group was informed that because of the large 
number of parts involved in the tubular gel molding system, the manufacture would be difficult. 
Additionally, it would be difficult for the user to seed the cells within the device properly and 
consistently during each use.  
After performing the brief qualitative analysis on the design alternatives, the team 
performed a quantitative analysis by generating a Best of Class chart to compare the relative 
ability of each of the five design alternatives to meet the weighted objectives.  Each of the 
design alternatives was ranked from 1 to 5, according to the ability of each alternative to fulfill 
the project’s objectives.  A score of 1 was given to the alternative that best addresses each of 
the project’s objectives.  If two design alternatives were determined to address a particular 
objective equally well, the score for both alternatives is the average of 1 and 2 (1.5).  The team 
used this approach as a way to compare each of the design alternatives.  Weighted scores for 
each of the design alternatives were calculated by multiplying the scores determined through 
the Best-of-Class chart by the weights previously assigned for each of the objectives.  Finally, 
the alternatives with the lowest total weighted scores were proposed to be the best design 
choices.  
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Table 7:  Best-of-Class Chart 
 DESIGNS 
Circumferential 
molding 
system 
Dog Bone 
molding 
system 
Fibrin/collagen 
micro-threads 
Series Molding 
System 
Tubular Gel  
Molding 
System 
OBJECTIVES Weight Score WS Score WS Score WS Score WS Score WS 
Consistent cell seeding 0.029 1.5 0.044 1.5 0.044 4 0.116 5 0.145 3 0.087 
Composition of provisional ECM 0.072 3 0.216 4 0.288 2 0.144 5 0.720 1 0.072 
Define differentiation conditions 0.064 1.5 0.096 1.5 0.096 5 0.320 3 0.192 4 0.256 
Appropriate culture medium 0.064 1.5 0.096 1.5 0.096 3 0.192 4 0.256 5 0.320 
Fiber integrity, uniform alignment 0.079 3 0.237 1 0.079 5 0.395 2 0.158 4 0.316 
Uniform fiber dimensions 0.057 2 0.114 3 0.171 5 0.285 4 0.228 1 0.057 
Fiber stability/viability over time 0.079 5 0.395 4 0.316 2 0.158 3 0.237 1 0.079 
Batch to batch fiber consistency 0.014 1 0.014 2 0.028 5 0.070 3 0.042 4 0.056 
Consistent initial anchor position 0.046 5 0.230 1 0.046 3 0.138 4 0.184 2 0.092 
Consistent anchor-fiber elongation 0.023 5 0.115 1 0.023 3 0.069 4 0.092 2 0.046 
Prevent fiber collapse 0.100 3 0.300 1.5 0.150 5 0.500 1.5 0.150 4 0.400 
Allow for electrical stimulation 0.061 5 0.305 1.5 0.092 1.5 0.092 4 0.244 3 0.183 
Easy to use 0.039 1.5 0.059 1.5 0.059 4 0.156 3 0.117 5 0.195 
Easy to clean 0.011 2 0.022 3 0.033 1 0.011 5 0.055 4 0.044 
Time efficient 0.002 1.5 0.003 1.5 0.003 4 0.008 3 0.006 5 0.010 
Cost effective 0.029 1.5 0.044 1.5 0.044 4 0.116 3 0.087 5 0.145 
TOTAL   2.290  1.568  2.770  2.913  2.358 
RANK   2  1  4  5  3 
 
According to the Best-of-Class chart, given our objectives, constraints, and expected 
functions, the top two systems were found to be the Dog Bone Molding System and the 
Circumferential Molding System.  These molding systems will allow for the creation of skeletal 
muscle fibers that are close to the dimensions of a native muscle fiber, based on the seeding 
channel width and height.  The molding systems are also very simplistic in design so they will 
not be difficult or time-consuming to manufacture.  
The quantitative results from the Best-of-Class chart supported our qualitative judgment 
based on the background and pros and cons of each device.  In particular, we anticipated that 
these methods would create uniform and mechanically stable fibers with a high degree of cell 
viability.  The advantages of a scaffold-free system for cell-based applications have been 
described in the Background section.  It was determined that important features of a scaffold-
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free system and a gel matrix allow for the requirements of three-dimensional structure, proper 
cell differentiation, and proper axial alignment.   
4.3 Feasibility Study/Experiments  
The list of materials needed for the manufacturing process of the device is shown below: 
- Acrylic  
- PDMS 
- Agarose 
It was determined that the use of these three materials is feasible since they are all readily 
available and their costs lie within the budget.  In terms of manufacturing the device to the 
intended specifications, however, it was found that using the techniques available through the 
machine shop would not be sufficient to develop a device with such small specifications (100 
μm, 250 μm, and 500 μm).  It was found that laser cutting, which is available at the WPI 
machine shop, can be used to create a device that contains channels at approximately 10x the 
specified dimensions.  
Other methods of manufacture such as photolithography and 3-D printing can be used 
to accurately create a device of the desired dimensions.  However, these methods are not 
available through the machine shop and are more expensive than using a traditional CNC 
machine for development of the device.  It was determined that it would not be feasible to 
outsource the machining at a high cost before performing preliminary testing on an affordable 
and more easily manufacturable device.  Therefore, the design specifications were revised to 
include channels that were ten times their original widths so that the device could be 
manufactured at WPI.  
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4.4 Mold Material Choice 
 Each of the proposed materials (Acrylic, PDMS, and agarose) was evaluated against a list 
of attributes that were determined to be desirable for a molding system.  For the template, the 
desired attributes were determined to be manufacturability and reusability.  For the final mold, 
the desired attributes were determined to be autoclavable, non-cytotoxic, moldable, optically 
transparent, diffusible for media, and non-adherent to cells.  
Table 8:  Comparison of Mold Materials for Template 
Attributes  Acrylic PDMS Agarose 
Manufacturable     
Reusable     
 
The desired characteristics for the final mold are listed in Table 8. Though the final mold 
should be moldable into a specified shape, the template should be sturdy to allow for the 
development of final molds from the template.  This template itself should be manufacturable 
so that it can take the exact shape and dimensions of the CAD drawing.  Of the three materials 
analyzed, only acrylic is manufacturable, so it must be used as the template.  
 Reusability is another important characteristic of the template because the ability to 
reuse the template as many times as necessary will allow for the development of several final 
molds from the template.  Reusability will eliminate any need to manufacture more than one 
mold using the machine shop and will allow the group to make all further molds in the lab.  
Both acrylic and PDMS are reusable, but since PDMS is not manufacturable, it is not suitable for 
use in the template.   
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Table 9: Comparison of Mold Materials for Final Mold 
Attributes  Acrylic PDMS Agarose 
Autoclavable     
Non-cytotoxic     
Moldable     
Optically transparent     
Media Diffusion     
Non-adherent to cells     
 
The desired attributes for the final mold (autoclavable, non-cytotoxic, moldable, 
optically transparent, diffusible for media, and non-adherent to cells) are shown Table 2in Table 
9.  The first desired attribute, autoclavable, was chosen because the proper sterilization of the 
mold is necessary to ensure that the cells that are seeded into the mold are in a sterile 
environment necessary for survival.  Of the three materials, only PDMS is autoclavable in its 
molded form. Acrylic is not autoclavable, and therefore, cannot be used for the material on 
which to directly seed the cells.  Agarose, in its molded form, is not autoclavable, but when it is 
in a liquid form prior to being molded, it can be autoclaved.  Therefore, either PDMS or agarose 
can be suitable for use as a final mold, in terms of autoclavability.  Since the cells will be seeded 
directly onto the mold and will be in contact with the mold, the material used for the final mold 
must also be non-cytotoxic.  PDMS and agarose are non-cytotoxic, while acrylic is cytotoxic.  
This indicates that acrylic is not suitable for use as the material of which the final mold is made.   
 Another desirable quality for the final mold is for it to be moldable.  This will allow for it 
to be molded to fit the shape of the template and will allow for multiple final molds to be 
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obtained from one template.  Both PDMS and agarose are moldable, while acrylic is not, 
indicating that either PDMS or agarose can be used as the final mold and that acrylic cannot.  
 The final mold should also be optically transparent to allow for optimal visualization of 
cells and the resulting fiber.  All three materials are optically transparent, indicating that any 
material’s optical properties are suitable for the final mold.  
One very important requirement of the final mold is that it should allow for media 
diffusion.  When the cells are seeded into a channel within the mold, they will still need 
nutrients from the media.  The media that is covering the mold from the top will not be able to 
penetrate throughout the forming muscle fiber through the sides and bottom of the fiber. 
Therefore, the media must be able to diffuse through the mold and into the sides and bottom 
of the fiber.  The only material of the three that allows for this diffusion is agarose, indicating 
that it is the optimal choice for the final mold material.  
The other critical attribute for the final mold material is that it should be non-adherent 
to cells.  This quality is important because a material that cells adhere to will not allow for the 
formation of a congruent muscle fiber.  This is because the cells may adhere to the material 
with greater strength than the strength with which the cells interconnect.  This will cause 
disconnects within the fiber.  Additionally, a material that is non-adherent to cells will allow for 
relatively easy removal of the muscle fiber from the mold once it has formed.  The only material 
of the three that is non-adherent to cells is agarose, which supports the use of agarose as the 
final mold material.  
Once the materials for the template and the final mold were chosen, it was determined 
that PDMS would be the optimal material choice for the negative mold.  Since it is sturdy and 
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reusable, one PDMS mold can be used for the development of several final agarose molds.  
Additionally, since PDMS is autoclavable, it can be sterilized and then be used as the negative 
for the final mold to ensure sterility of the final agarose mold.  
4.5 Manufacture of the Primary Mold 
Once it was determined that the two possible molding shapes would be a dog bone 
mold and circumferential mold, the group decided to test each of the molds with three 
different channel widths that could form fibers of varying diameters.  To minimize the number 
of components to each device, the device was conceptualized with three dog bone molds on 
one block and three circumferential molds on another block.  By placing three molds on one 
block, the seeding process can be expedited.  
In designing our device, the material proposed for the double negative mold was acrylic. 
Laser cutting can be used to accurately etch the design into one of two materials: acrylic poly 
(methyl methacrylate) or Delrin (polyoxymethylene).  Since acrylic was readily available in the 
WPI machine shop, it was chosen as the material for the template.  
By developing a double negative mold using a material that is sturdy and will remain 
usable for the length of the project, negative molds can be developed any time that they are 
needed.  The negative mold would then be formed by pouring PDMS into the double negative. 
Using a negative mold made of a stable and durable material like PDMS, several of the final 
molds can be made in a timely manner, without the need to machine a new mold.  Each final 
mold will be made by pouring agarose into the negative mold made of PDMS.  Each agarose 
mold will be used for a seeding experiment and then discarded once the fiber has formed and 
has been removed from the mold.  
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4.6 Device Specifications 
The mold was initially developed according to the set of initial specifications. 
Preliminary tested indicated, however, that the specifications would need to be revised for 
optimal fiber formation.  Therefore, a revised mold was developed according to a new set of 
specifications.  
4.6.1 First Iteration of Molding Device 
In order to manufacture the device, a set of specifications that includes the dimensions 
of the device and the materials that make up the device must be determined.  For the dog bone 
molding system, it was determined that three different dog bone molds would be made onto 
the same block in order to facilitate simultaneous testing of three molds of varying dimensions.  
Initially, the channel widths that were chosen were 100 µm, 250 µm, and 500 µm.  The 100 µm 
channel width was chosen because this is the diameter of a native skeletal muscle fiber and 
ideally, the device would be able to produce a muscle fiber as close to native dimensions as 
possible.  The 250 µm and 500 µm channels were chosen in case the 100 µm channel was too 
difficult to seed with cells because of its very small size.  However, from conversations with 
staff at the WPI machine shop, the group was informed that channels of such small widths 
could not be machined using the CNC machines available at the machine shop.  The dimensions 
would have to be enlarged to 10x their current size for the device to be manufactured at all and 
would need to be enlarged to 40x their current size for the device to be manufactured with 
accuracy.  
The group decided that accuracy of the mold’s outline was not as large of a concern as 
the objective of creating a muscle fiber that approximates native skeletal muscle as much as 
 70 
 
possible.  Therefore, it was determined that the channel widths would be increased to 10x their 
original values for channel widths of 1 mm, 1.5 mm, and 2 mm.  The post diameters on each 
end of the dog bone were chosen to be 2 mm so that the posts would be sturdy enough to 
withstand the contraction of the muscle fiber once it forms.  A post with too small of a diameter 
might break once the muscle fiber becomes continuous throughout the mold and begins to 
contract against the post.  The heights of the posts and depths of the channels were chosen to 
be 2 mm, the same value of the largest channel diameter.  Assuming that the muscle fiber that 
forms will be perfectly cylindrical, the post height and channel depth would have to be as least 
as large as the channel width.  All post heights were chosen to be 2 mm, even for the smaller 
channel widths, since a post that is higher than the channel is wide will still allow for a 
cylindrical fiber to form.  
For determining the specifications of the circumferential molding system, which 
contains three circular molds on one block, the same channel widths of 1 mm, 1.5 mm, and 2 
mm were chosen for the reasons stated previously.  Since the dog bone molds were based on 
of the concept of the circumferential molds used in Professor Rolle’s lab, the depths of the 
channels were found using the ratio found in Professor Rolle’s molds.  The ratio of channel 
width to channel diameter was 1:1.75 in Professor Rolle’s molds, so by using the same ratio for 
the circumferential device, a channel diameter of 1 mm would correlate with a channel depth 
of 1.75 mm, a channel diameter of 1.5 mm would correlate with a channel depth of 2.63 mm, 
and a channel diameter of 2 mm would correlate with a channel depth of 3.5 mm.  The CAD 
 71 
 
representation of the mold is shown in Figure 16. 
 
Figure 16: CAD Representation of Initial Dog Bone Mold 
4.6.2 Second and Final Iteration of Molding Device 
Preliminary testing of the initial mold suggested that the specifications were not optimal 
for proper fiber formation.  It was found that the channel width that was most effective in 
forming myofibers was the smallest channel width of 1 mm.  Therefore, the new mold was 
manufactured with all three dog bones with channels 1 mm in width.  Additionally, it was 
determined that an increase in channel depth and post height would be beneficial since it 
would ensure longer anchoring of the fiber around the post.  Therefore, the channel depth was 
changed from 2 mm to 3.5 mm.  The CAD representation of the final iteration of the molding 
device is shown in Figure 17.  
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Figure 17: CAD Representation of Final Dog Bone Mold 
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Chapter 5: Design Verification 
From the design process, it was determined that the dog bone mold would be machined 
of acrylic and would be seeded cells within a matrix of collagen or fibrin gel.  The primary acrylic 
molds were developed through the WPI Machine Shop and subsequently, the PDMS and then 
the agarose molds were made.  Gels were then prepared, seeded with cells, and placed into the 
seeding channels within the dog bone molds.  The cells and any resulting fiber were then 
subjected to BrdU staining to ensure proper proliferation of cells, myosin staining to ensure 
differentiation into a muscle fiber, and live/dead staining to ensure cell viability.  The final fiber 
was also subjected to electrical stimulation to demonstrate the functionality of the tissue.  
5.1 Development of Final Molds 
Once the double negative mold was made from acrylic in the machine shop, the 
negative mold and the final mold had to be developed.  As shown in Figure 18 below, the acrylic 
double negative mold would lead to a PDMS negative mold, which would, in turn, lead to the 
final agarose mold.  
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Figure 18:  Schematic of Double Negative Mold to Final Mold 
 The primary mold made of acrylic that was machined through the WPI machine shop is 
shown in Figure 19. 
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Figure 19: Primary Mold of Acrylic 
A mixture of PDMS and curing agent (10:1 ratio of PDMS to curing agent) was poured 
onto the acrylic mold.  The PDMS/acrylic complex was placed in the de-gasser for 1 hour to 
eliminate any bubbles followed by 4 hours in the oven at 60° C to allow for polymerization of 
the PDMS.  Once the de-gassing and polymerization was complete, the PDMS negative mold 
was removed from the acrylic mold.  The PDMS mold is shown in Figure 20.  
 
Figure 20: PDMS Mold Developed from Acrylic Mold 
 In order to form the agarose mold, 2.5% agarose was dissolved in DMEM within a glass 
container and autoclaved using the liquid cycle.  Initially, 2% agarose was used to make the final 
molds but it was determined that in order to increase the rigidity of the posts and prevent 
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further tissue collapse, a higher concentration of agarose should be used.  The PDMS templates 
made previously were autoclaved using the gravity cycle.  Autoclaved tongs were used to 
transfer the PDMS template into the hood and the autoclaved agarose was then filled into the 
mold using a micropipetter.  The pipetting was done slowly to avoid bubble formation.   
After being left in the hood for 10 minutes, the PDMS/agarose complex was transferred 
within a plate into the refrigerator for storage until use.  The mold was then transferred back 
into the hood and using scalpel blades, the agarose mold was carefully removed from the PDMS 
template.  The agarose mold, shown in Figure 21, was then placed within a 100 mm petri dish 
and incubated in DMEM for two days prior to seeding.   
 
Figure 21:  Agarose Mold Made from PDMS Mold 
5.2 Culturing of C2C12 Cells 
Proliferation and differentiation media was used in experiments with C2C12 cells to 
sustain the cells during each phase of fiber formation.  The base of the proliferation media was 
50%/50% DMEM/F12, and it was supplemented with 10% Fetal Bovine Serum (FBS), 1% 
Glutamine, and 1% Penicillin/Streptomycin.  For differentiation media, the base was similarly 
50%/50% DMEM/F12, and was supplemented by 1% ITS, 1% Glutamine, and 2% Horse Serum.  
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The cell culturing procedure for C2C12 cells begins by breaking down the extracellular 
matrix holding the cells to the surface of the plate by removing the media within the flask and 
adding 3.5 mL of trypsin to the flask.  Trypsin is a protease, which means that it breaks down 
protein, and therefore, is able to detach the cells from the plate’s surface.  After being placed in 
the incubator for 7 minutes, the flask was viewed under the microscope and if the cells were 
found freely floating across the surface of the plate, they were centrifuged.  If most of the cells 
were found to be not detached after seven minutes in trypsin, they were placed back into the 
incubator for 3 more minutes. The cells must not be left in trypsin for greater than 15 minutes 
because the trypsin will begin to break down the cells themselves.  5 mL of medium was then 
added to the cells in trypsin since the FBS within the medium inactivates the trypsin.   
This solution was pipetted into a 15 mL conical tube and at this point, 100 μL of the cell 
suspension was removed from the conical tube and placed in an Eppendorf tube.  100 μL of 
trypan blue was added to the same Eppendorf tube and then 20 μL of the solution was placed 
into the hemocytometer to determine the cell concentration.  The cell count was performed 
according to the procedure in Appendix B.    
The cell suspension remaining in the conical tube was centrifuged for 5 minutes at an 
RCF of 700 xg.  At the end of the five minutes, a cell pellet was seen at the bottom of the conical 
tube, which was otherwise filled with the trypsin/media solution.  The solution was aspirated 
from the conical tube and the cells were resuspended in the appropriate amount of medium for 
re-plating or experiments.  
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5.3 Preparation of Gels 
Two types of gels, collagen gel and fibrin gel, were investigated as potential provisional 
matrices within which to resuspend cells prior to seeding within the channel of the mold.  
5.3.1 Collagen Gel 
The collagen gel was prepared with the addition of several components to form a 
solution, which is then added to bovine Type 1 Collagen.  First, culture medium was added to 
FBS, which was then added to 5X DMEM, which was then added to sodium hydroxide (NaOH), 
which was then added to acetic acid.  Next, the solution was added to cell solution of the 
correct density for the mold that it was being seeded into.  Finally, the cell suspension was 
added to the 2 mg/mL collagen. This process is represented in Figure 22.  
 
Figure 22:  Representation of Collagen Gel Components and Cell Suspension 
 
5.3.2 Fibrin Gel 
The components of fibrin gel are fibrinogen and thrombin. The fibrin gel was made 
according to the protocol described in Appendix C3.  Briefly, calcium chloride (CaCl2) solution 
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was mixed with thrombin, which was then mixed with fibrinogen. In the formation of fibrin 
from its constituents, thrombin initially catalyzes the conversion of fibrinogen into fibrin 
monomers, and then the fibrin monomers polymerize into fibrin strands.  The role of calcium in 
forming fibrin is that it is a co-factor in the process, which causes cross-linking of the fibrin 
strands, thereby providing cohesiveness to the gel.  The time required for polymerization of the 
fibrin gel was approximately 10-15 minutes.  Within this time frame, the cells were 
resuspended within the appropriate amount of gel to seed the mold.  This process is 
represented in Figure 23.  
 
 
Figure 23:  Representation of Fibrin Gel Components and the Process of Cell Suspension 
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5.4 Seeding of Cell-Gel Solution 
 The seeding of the cell-gel solution was dependent on the volume available within the 
seeding channel.  In order to measure this volume, a measured amount of water was slowly 
pipetted into the seeding channel.  The three dog bone molds created on the same base had 
seeding channels with diameters of 1 mm, 2.5 mm, and 5 mm, and the volumes of water that 
could fit within the seeding channel were measured to be 60 μL, 80 μL, and 100 μL, 
respectively.  Additionally, the number of cells to be seeded within each well was calculated 
based on the surface area of the seeding channel.  It was determined that for the 1 mm 
diameter seeding channel, the number of cells would be 2 million cells.  For the 5 mm diameter 
seeding channel, the number of cells seeded into the mold would be 3 million cells.  
5.4.1 Collagen Gel 
 After the collagen gel containing cells was prepared, it was pipetted into the molds and 
placed in the incubator for 1-2 hours.  Within 1-2 hours, the polymerization of the collagen gel 
was complete, so the mold was removed from the incubator, filled with media for adequate 
nutrition and hydration, and placed back into the incubator for cell growth. This step-by-step 
process is depicted in Figure 24.  
 
Figure 24: Representation of Seeding of Collagen Cell-Gel Solution into Dog Bone Mold 
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5.4.2. Fibrin Gel 
 The fibrin gel, once prepared, and mixed with cells, was then seeded into the molds 
using a pipettor.  After 15 minutes of being placed in the incubator for polymerization of the 
fibrin gel, the mold was removed from the incubator, filled with media for adequate hydration, 
and then placed back into the incubator for cell growth. This process is shown in Figure 25.  
 
Figure 25: Representation of Seeding of Fibrin Cell-Gel Solution into Dog Bone Mold 
5.5 Immunocytochemistry 
Several immunocytochemistry assays were performed in order to characterize the 
behavior of C2C12 cells.  A study of the progression through proliferation and differentiation of 
C2C12 cells was performed to understand the time point within the cell cycle at which the cells 
begin differentiation.  This time point is important because when in their proliferation phase, 
cells do not produce ECM components, but while in the differentiation phase, the cells are 
producing ECM components, which contribute to structural integrity.  Fiber formation would, 
therefore, be enhanced if the mold was seeded with cells entering differentiation since the cells 
would produce ECM components immediately and form a strong tissue reinforced with ECM.  
Myosin staining was performed in order to determine whether C2C12 cells cultured on a 
plate are capable of forming mature myofibers.  This study was performed for the 
characterization of C2C12 cells in determining whether myofibers would form if the cells were 
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left to proliferate without the addition of differentiation media and to perform a comparison 
between myofiber formation on fibrin and collagen gels.  
5.5.1 Bromodeoxyuridine (BrdU) Assay for Cell Proliferation 
A BrdU incorporation assay is a common assay to detect proliferating cells in culture.  
BrdU is a synthetic nucleoside that is an analog to thymidine.  The mechanism of BrdU staining 
is that during the S phase of the cell cycle, BrdU incorporates into the replicating DNA by 
substituting for thymidine.  Once the BrdU is taken up by the cells, specific antibodies are used 
to detect BrdU using immuno-fluorescence.  However, the antibodies can only bind BrdU once 
the DNA is denatured.  The denaturation process is usually done by exposing the cells to heat or 
acidic conditions.  
 An experiment was set up for the determination of the time point at which 
differentiation occurs.  The information gained from this study could be used for more accurate 
cell seeding into the molds since the optimal time point at seeding is at the beginning of the 
cells’ differentiation phase.  While the cells are in their proliferative phase, the number of cells 
increase but the cells do not produce extracellular matrix components.  Once the cells enter the 
differentiation phase, they begin to form extracellular matrix, which provides integrity and 
structure between the cells.  Therefore, the seeding of cells at the appropriate cell density into 
the molds at the time of differentiation would enhance the structural integrity of the fiber since 
the extracellular matrix proteins would be formed immediately.  
 The experiment was set up with a total of five 24-well plates (Plate #1 – Plate #5), each 
with four different cell densities (5,000 cells/well, 10,000 cells/well, 15,000 cells/well, and 
20,000 cells/well).  After seeding the cells into the 24 well plates, the cells were allowed to 
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proliferate until the cells at the highest density reached a confluency of 80-90%.  At this point, 
the media within the wells was switched to differentiation media.  This time point was recorded 
as Day 0.  
 On Day 1, the cells in Plate #1 were fixed according to the protocol in Appendix B2. On 
Day 2, the cells in Plate #2 were fixed, on Day 3, the cells in Plate #3 were fixed, on Day 4, the 
cells in Plate #4 were fixed, and on Day 5, the cells in Plate #5 were fixed.  After being fixed, all 
plates were stained at once for BrdU and were visualized using fluorescence microscopy.  
 The Hoescht stain used in the protocol would stain for all of the nuclei present in the 
sample, while the BrdU stain would stain for all of the nuclei in the proliferative phase of the 
cell cycle.  If the majority of cells stained blue were also stained green, this would indicate that 
most cells within the sample are within their proliferative phase.  If most of the cells stained 
blue were not also stained green, this would indicate that most cells within the sample had 
exited the proliferative phase and begun differentiation.   
5.5.2 Myogenic Differentiation Study  
 A myosin staining assay can be used to detect myosin protein within the sample of 
interest.  Presence of myosin within the aligned fibers indicates the presence of contractile 
units and maturation of the cells into contractable fibers.  A myosin stain was performed on 
plates with cells of varying densities, which were allowed to proliferate for 10 days.  The study 
was performed to characterize C2C12 cells and determine the natural differentiation potential 
and maturation of the cells without the addition of any differentiation media.  The proliferation 
study was conducted in a 24 well plate with cell densities of 5,000 cells to 20,000 cells at 1,000 
cell intervals.  Cells were seeded at the appropriate densities into each well and 1 mL of 
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proliferation media was added on top of the cells.  The proliferation media was changed every 3 
days during the course of the study.  
5.6 Cytotoxicity Study 
A cytotoxicity study was performed in order to investigate the effects of the collagen 
and fibrin gels used in the cell seeding process on C2C12 cell maturation and to observe any 
differences in cell differentiation based on the type of gel used.  For this study, cells of varying 
densities were seeded into wells coated with collagen and fibrin and images were taken daily in 
order to follow the behavior of the cells.  The gel study was conducted in a 24 well plate with 
cell densities of 5,000 cells/well, 10,000 cells/well, 15,000 cells/well, and 20,000 cells/well for 
each the collagen and fibrin gel.  
Initially, four wells of the plate were coated with 150 μL of collagen gel each and four 
wells of the plate were coated with 150 μL of fibrin gel each.  The cells were then added at the 
appropriate densities so that four different cell densities were added to each gel-coated well. 
Then, 1 mL of proliferation media was added to each well. After reaching 80-90% confluency, 
the media was switched to differentiation media, which was replaced every 3 days through the 
course of the study.  
5.7 Live/Dead Assay 
Once the tissue had formed within the mold, it was necessary to determine cell viability 
of the formed fiber.  A live/dead staining was performed to visualize the parts of the tissue with 
live cells and the parts of the tissue with dead cells.  Hoechst staining was used to visualize all 
nuclei within the fiber and propidium iodide at a concentration of 500 nM was used to visualize 
only the dead myocytes. It would then be inferred that the cells stained by the Hoechst stain 
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but not stained by propidium iodide were live cells.  The following protocol was used to 
perform the live/dead stain: 
1. Aspirate PBS from the wells containing the tissue fibers 
2. Add PBS (1.0 ml/well for 24-well or 0.5 ml/well for 48-well plate) and add 1 µg/ml 
Hoechst 33342 (stock is 1 mg/ml) and incubate for 10 min at RT 
3. Aspirate the PBS and wash 2X with PBS 
4. Dilute propidium iodide 1:3000 in PBS+0.05% Tween-20 
5. Add propidium iodide solution (300 µl/well for 24-well plate or 900 µl/well for 48-well 
plate) and incubate at RT for 10 min. 
6. Aspirate antibody solution and wash 2X with PBS and add PBS (1.0 ml/well for 24-well or 
0.5 ml/well for 48-well plate). 
7. Cells are ready for observation by fluorescence microscopy. Plates can be stored at 4C 
wrapped in foil to protect from light.  
5.8 Contractile Testing/ Electrical Stimulation Testing 
 Some of the tissues that had formed were also tested for contractile ability since a fully 
formed fiber should contain the appropriate contractile units for contractility upon electrical 
stimulation.  Depolarization of the membrane potential can allow for the manipulation of 
intracellular calcium currents through the use of electrical pulses, and is known to accelerate 
sarcomere assembly in myofibers (Fujita et al., 2007; Nedachi et al., 2008).  The team used a 
pair of electrodes interfaced with a BIOPAC system to supply a series of electrical pulses to both 
ends of the formed tissue in each agarose dog bone mold.  Initially, the stimulator was set up to 
provide 5 volts for a 4 millisecond pulse length at 500 millisecond intervals.  A number of 
attempts to test for contraction were carried out at 60 second intervals.  Jumper wires were 
attached to the stimulator’s positive and negative electrode leads and these were placed on 
either side of the tissue immersed in medium within the agarose dog bone mold channel.  After 
testing for contraction at 5 volts, contraction was also tested using 10 volts at the same pulse 
length and time intervals.  The set-up for contractility testing is shown in Figure 26.  
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Figure 26: Jumper Wires Connected to Both Ends of Tissue Construct 
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Chapter 6: Final Design & Validation 
6.1 Cell Seeding Experiments 
The cell seeding experiments performed allowed the team to determine the parameters 
by which the most contiguous tissue would form and remain anchored around the posts.  
Initially, the first version of the dog bone mold was tested, followed by a modified dog bone 
mold which was expected to allow for the development of more congruent tissue constructs. 
The team seeded different cell densities within the molds and compared the resulting tissue 
when seeding the cells without a gel, versus seeding them in a collagen or fibrin gel matrix.  It 
was determined that the optimal cell density at which to seed the cells in the agarose dog bone 
molds is  3.5 million cells per mold, and the most contiguous tissue developed after seeding this 
density using no gel.  The following are the results obtained using no gel, versus using collagen 
or fibrin as matrices.  
6.1.1 Initial Dog Bone Mold 
 The team analyzed the results of the initial dog bone mold and determined that its 
dimensions were not the optimal ones.  The depth of the seeding channel, which was 2 mm, 
was found to be insufficient to allow the seeding of a cell-gel solution since it provided 
inadequate space for media retention.  As a result, the group was required to flood the mold 
with media, which often caused detachment of the tissue from within the seeding channel. 
None of the experiments performed using this first iteration of the mold developed contiguous, 
full tissues, and none of the tissue fragments were found to be successfully anchored around 
the posts. 
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6.1.1.1 No-gel Cell Seeding 
After different attempts at forming a contiguous, full tissue, the team was unable to 
attain the desired results throughout the entire seeding channel.  As seen in Figure 27, the 
tissue had adopted the post’s circular shape at one of its ends but had come off the post one 
day after cell seeding at a density of 3.5 million cells per mold.  Although not shown in Figure 
27, none of the experiments performed using no-gel seeding systems caused the development 
of a full, contiguous tissue.  The tissue was found ruptured at one or two different spots, as 
soon as one day post-seeding.  
 
Figure 27: Tissue formation at 1 day post-seeding of cells seeded without a gel in initial mold at 3.5 million 
cells/mold (5X) 
6.1.1.2 Collagen Gel Seeding 
 The results obtained after seeding a density of 3.5 million cells into a collagen matrix 
also resulted in fragmented tissue constructs.  One day post-seeding, tissue fragments were 
found throughout the seeding channel.  As shown in Figure 28, some of the fragments 
appeared as if they had begun contracting into a circular shape, instead of maintaining their 
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linear orientation.  None of the tissue fragments formed when using collagen as a matrix were 
found to be anchored one day after seeding. 
 
Figure 28: Tissue formation at 1 day post-seeding of cells seeded in collagen gel in initial mold at 3.5 million 
cells/mold (5X) 
 
6.1.1.3 Fibrin Gel Seeding 
The results obtained after seeding the molds with a density of 3.5 million cells in a fibrin 
matrix resulted in fragmented tissue, and then contracted tissue fragments.  Seeding the cell-
matrix solution within the small dimensions of the seeding channel was particularly difficult 
when using fibrin as its components are more viscous than those of collagen.  As seen in Figure 
27, the cell distribution was inconsistent throughout the channel, as the tissue had ruptured 
and there were no additional tissue fragments in close proximity to the one shown in the 
picture.  The tissue fragments were found to not be anchored at the posts.   
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Figure 29: Tissue formation at 1 day post-seeding of cells seeded in fibrin gel in initial mold at 3.5 million 
cells/mold (5X) 
6.1.2 Revised Dog Bone Mold 
 After a thorough analysis of the results of the initial dog bone mold, the group decided 
to modify the dimensions of the design and machine a new mold.  The increase in channel 
depth and post height, to 3.5 mm, was found to improve the overall tissue formation within the 
seeding channel.  The best results were obtained when the cells were seeded into the mold 
without a gel matrix.  
6.1.2.1 No-gel Cell Seeding 
The results observed after seeding 3.5 million cells in the molds without using any gel 
showed optimal tissue formation.  At day 1, represented in the rightmost section of Figure 30, 
the tissue was fully anchored around the posts, and there were no ruptured areas within the 
tissue construct.  The cell distribution appeared to be very consistent throughout the tissue. As 
seen in the rightmost image in Figure 31, the tissue formed contiguously throughout the entire 
channel, and had remained anchored around both posts. 
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6.1.2.2 Collagen Gel Seeding 
Seeding cells embedded within a type I collagen matrix in the seeding channels within 
the molds resulted in the least contiguous tissue formation.  At day 1, as shown by the first 
picture in Figure 30, the tissue was somewhat anchored around one of the posts, but was fully 
ruptured below the post.  Also, as shown in Figure 31, the entire tissue was fragmented at 
various locations throughout the channel and at the posts.  Loss of anchorage occurred at the 
bottom post as the tissue fragment on the bottom of the seeding channel had adopted the 
circular post shape but was no longer connected to the remaining tissue.   
6.1.2.3 Fibrin Gel Seeding 
Using fibrin as a matrix gave significantly better results as compared to collagen, but 
were not comparable to the results obtained from seeding the cells without a gel matrix.  At 
day 1, the resulting fiber was anchored on one of the posts, as seen in the middle picture of 
Figure 30, but the cell distribution close to the post seemed to be slightly less than ideal, 
indicating that it could be prone to rupturing.  As shown in Figure 31, significantly better tissue 
formation was found throughout the entire channel, as compared to the collagen gel seeding 
experiment, but the fibrin tissue was still ruptured and lost its anchorage at the bottom post.  
 
Figure 30: Tissue Formation 1 day Post-Seeding at 3.5 million cells/mold using Collagen, Fibrin, and No Gel 
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Figure 31: Complete Tissue Formation 1 day Post-Seeding at 3.5 million cells/mold using Collagen, Fibrin, and No 
Gel 
6.2 Immunocytochemistry 
The results obtained from the BrdU staining and myosin staining allowed the group to 
characterize the behavior of C2C12 cells under various conditions.  The BrdU differentiation 
study indicated the time point at which the cells began differentiation and the myosin study 
confirmed the presence of mature myofibers within the sample.  
6.2.1 BrdU Staining 
Results from the BrdU study showed consistent levels of proliferation and 
differentiation across all four cell densities that were tested, indicating that cell density does 
not affect the time point at which cells begin differentiation.  At all densities, proliferation was 
found to decrease sharply by Day 5, indicating that Day 5 is the time point when cells begin 
differentiation.  
In the following images, the green staining is the BrdU stain, which represents 
proliferative cells, while the blue staining is the Hoechst stain, which represents all cells, 
regardless of their position in the cell cycle.  The side-by-side images of each BrdU stain and 
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Hoechst stain were taken from within the same frame of view. Images taken from a well of 
seeding density of 10,000 cells/well are shown below, and images from all other seeding 
densities tested can be found in Appendix A.  
 
 
 Figure 33: Day 2 BrdU Stain (10,000 cells/well)  Day 2 Hoechst Stain (10,000 cells/well) 
  
Figure 34: Day 3 BrdU Stain (10,000 cells/well)   Day 3 Hoechst Stain (10,000 cells/well) 
50 µm 50 µm 
50 µm 50 µm 
Figure 32: Day 1 BrdU Stain (10,000 cells/well         Day 1 Hoechst Stain (10,000 cells/well)  
50 µm 50 µm 
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      Figure 35: Day 4 BrdU Stain (10,000 cells/well)  Day 4 Hoechst Stain (10,000 cells/well) 
 
     Figure 36: Day 5 BrdU Stain (10,000 cells/well)  Day 5 Hoechst Stain (10,000 cells/well) 
As shown by the images, the number of proliferating cells remained relatively constant 
from Days 1 through 4.  At Day 5, however, there was a sharp decrease in the number of cells 
undergoing proliferation.  
The graph in Figure 37 presents quantitative data of number of cells undergoing 
proliferation and total number of cells at time points throughout the study.  The data was 
obtained by overlaying a grid onto the images, counting 10 boxes from the grid, finding the 
average number of cells per box, and multiplying by the total number of boxes in the image to 
determine the total cell count.  
50 µm 50 µm 
50 µm 50 µm 
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Figure 37: Number of Cells Undergoing Proliferation and Total Number of Cells at Various Time Points 
The quantitative measurements from the graph support the qualitative assessments 
from the fluorescence images.  The graph shows relatively stable levels of proliferative cells 
from Days 1 through 4, and a sharp decline in proliferative cells at Day 5.  Only cell numbers 
from Days 1, 4, and 5 were counted because qualitative findings from the images indicated that 
the most significant discrepancy in cell number occurred between Days 4 and 5.  
6.2.2 Myogenic Differentiation Study  
Images obtained from the proliferation study showed formation of mature myofibers in 
all wells, as evidenced by the myosin staining that was found to be present along the fused 
nuclei of the myofiber.  The staining was performed such that the myosin staining would stain 
for the myosin protein found in mature myofibers and the Hoescht staining would stain for all 
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cells found within the well.  Figure 38 shows the myofibers that formed within a well, with the 
myosin represented by the green staining, and the cells represented by the blue staining.  
 
Figure 38: Nuclei Fused to form Myofibers 
 In this image, the presence of a myofiber is indicated by the three fused nuclei that 
make up the myofiber containing myosin protein.  
6.3 Cytotoxicity Study 
Images taken at several time points from the cytotoxicity study were used to determine 
the behavior of C2C12 cells when placed on collagen and fibrin gels.  Shown below in Figure 39 
and Figure 40 are images of the cells at Day 4 of proliferation, which were seeded at 10,000 
cells/well onto collagen and fibrin gels, respectively.   
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Figure 39: Cells on Collagen Gel at Day 4 of Proliferation 
 
 
Figure 40: Cells on Fibrin Gel at Day 4 of Proliferation 
 
These two images indicate that the cells were proliferating appropriately when seeded 
onto collagen and fibrin gel substrates.  
Shown below in Figure 41 and Figure 42 are images of the cells at Day 1 post-
differentiation, which were seeded at 10,000 cells/well onto collagen and fibrin gels, 
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respectively.  These images can be used to understand the degree of differentiation that cells 
seeded onto each type of gel undergo once switched to differentiation media.  
 
Figure 41: Cells on Collagen Gel at Day 1 Post-Differentiation 
 
 
Figure 42: Cells on Fibrin Gel at Day 1 Post-Differentiation 
 
These images show that cells seeded onto the fibrin gel differentiated to a greater 
degree than the cells seeded onto the collagen gel.  This can be seen by the amount of 
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unidirectional alignment shown by the cells seeded on the fibrin gel, which is not present in the 
cells seeded onto the collagen gel.  
6.4 Live/Dead Staining   
 Results from the live/dead staining performed on a tissue sample allowed the team to 
identify the regions of the tissue containing live cells and the regions of the tissue containing 
dead cells.  The staining was performed with a Hoechst stain to visualize all of the cells present 
in the tissue and propidium iodide to visualize dead cells.  In Figure 43, the cells stained blue 
represent all cells within the tissue sample, while the cells stained red indicate all dead cells. 
The white dashed line represents the approximate fiber boundary.  
 
Figure 43: Live/Dead Stain of Tissue Sample 
 The tissue staining shown in Figure 31 shows staining of cells is apparent throughout the 
fiber, while the dead cells are concentrated towards the center of the tissue sample.   
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6.5 Contractility Testing 
The tissues formed from cell seeding into the mold were subjected to electrical pulses 
ranging from 5 to 10 volts for a 4 millisecond pulse length at 500 millisecond intervals.  After 
testing various tissue samples, no contraction was observed in any of the tissues.  Bubbles 
formed around the jumper wires providing the electrical pulses, indicating that the electrical 
stimulus was being transferred to the agarose mold, but none of the fibers showed contractile 
function after the pulses were applied for 60 seconds.  
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Chapter 7: Discussion 
7.1 Project Discussion 
The main focus of this project was to design, develop, and test a scaffold-free system 
that can be used for the development of skeletal muscle fibers in vivo.  Once the system was 
manufactured, it was tested with the seeding of myogenic cells at various seeding densities into 
the mold in no-gel and gel-embedded systems.  C2C12 cells were characterized by fluorescently 
labeling cells seeded onto plates to determine the time point at which the cells exit the 
proliferation stage of the cell cycle and enter differentiation, as well as to determine whether 
the development of mature myofibers is possible in vitro.  
Cell seeding experiments indicated that 3.5 million cells/mold is the optimal seeding 
density for formation of congruent tissue.  Densities lower than 3.5 million cells/mold resulted 
in formation of fragmented tissue due to inadequate cell-to-cell contact throughout the mold. 
Densities higher than 3.5 million cells/mold resulted in clumps of cells in addition to the formed 
tissue, indicating that the cells were not incorporated into the tissue, and therefore, not 
necessary for fiber formation.  
Comparison of seeding cells alone into the mold versus seeding cells embedded in a 
collagen or fibrin gel into the mold indicated that seeding cells alone is a more effective means 
of forming congruent tissue.  Cells seeded into the mold at the appropriate density of 3.5 
million cells/mold, without a gel matrix, were able to form completely congruent tissue 
throughout the dog bone structure by Day 1 post-seeding.  The multiple sites of fragmentation 
that occurred in the tissue when cells were seeded in the collagen gel and the occasional 
fragmentation that occurred in the tissue when cells were seeded in the fibrin gel indicate that 
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the presence of the gel surrounding the cells inhibited proper tissue formation.  This inhibition 
could be due to the physical presence of the provisional gel matrix preventing the complete 
proliferation of cells throughout the mold.  
 The BrdU study performed on the C2C12 cells cultured into a 24-well plate allowed for 
the determination of the time point of differentiation.  Since the images taken of each time 
point indicate that the number of proliferative nuclei, relative to total nuclei, decreased 
drastically from Day 4 to Day 5, Day 5 was determined to be the point at which the cells switch 
to the differentiation phase.  The quantitative results displayed in Figure 29 also show that 
there were similar levels of proliferations at Days 1 and 4, but significantly less proliferation 
levels at Day 5.  
Due to time constraints in the project, the results of the BrdU study were not 
incorporated into the mold seeding to optimize tissue formation.  In the future, however, the 
study suggests that the optimal time point at which to seed cells into the mold would be at Day 
4.  This is because cells begin to form ECM components while in the differentiation phase and 
these ECM components would contribute to increased cohesiveness and structural integrity of 
the myofiber.  Therefore, seeding cells at the time point at which differentiation begins, rather 
than during the proliferative stages, as was done in the seeding experiments, could facilitate 
more congruent tissue formation.  This study also indicates that if the cells are seeded while in 
proliferation, as was done in the seeding experiments, the tissue must retain its conformation 
for at least 4 to 5 days, in order to have enough integrity to be manipulated for 
immunocytochemistry assays and contractile testing.  
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 Myosin staining performed on cells seeded within 24-well plates and allowed to 
proliferate within 10 days showed that there was myosin present in the conformation of a 
myofiber within the tissue. The fused nuclei in Figure 38 indicate myofiber formation and the 
myosin staining indicates maturation of the myofiber. These results suggest that in vitro 
development of skeletal muscle tissue can lead to the formation of mature myofibers. The 
findings from the myosin staining indicate that if the skeletal muscle tissue formed from within 
the dog bone mold remains viable for at least 10 days, it should contain myosin protein and 
appropriately stain for myosin, indicating its maturation.  
 The cytotoxicity study performed indicated that neither of the gels have negative effects 
on cell behavior.  Cells seeded onto both collagen and fibrin gels showed proper proliferation, 
indicating that the gels are not cytotoxic.  After addition of differentiation media to the cells, 
the cells seeded onto the fibrin gel were found to have better differentiation and alignment 
than those seeded onto the collagen gel.  The limited alignment found in the cells seeded onto 
the collagen gel correlate with the fragmentation found in the seeding experiments with cells 
seeded within a collagen gel.  The inadequate differentiation of cells, when embedded within a 
collagen gel, could have caused the tissue fragmentation.  
 The live/dead stain performed on the myofibers indicated that the majority of cells in 
the center of the tissue construct were dead.  This result could be due to inadequate media 
diffusion into the center of the tissue, due to its thickness, which is greater than that of native 
myofibers.  Additionally, the loss of tissue anchoring that occurred prior to the assay being 
performed could have caused cell death.  Complete anchoring of skeletal muscle tissue is 
required for proper formation of skeletal myofibers, cell viability, and formation of contractile 
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units.  Lack of anchoring could, therefore, be a contributing factor to the cell death observed at 
the center of the tissue construct.  
 Contractility testing was performed on the tissues that formed from cell seeding 
experiments by stimulating the tissue with electrodes that delivered 5 volts at 4 ms pulses.  No 
contractions were observed in the tissue.  The reason for the lack of response to electrical 
stimulation could be cell death within the tissue, due to either a loss of anchoring or insufficient 
media diffusion throughout the tissue.  After Day 1 post-seeding, most formed tissues were 
found to have a loss of anchoring due to the tissue surrounding the post moving off of the post 
and settling within the channel.  
This could be due to the contractile force produced by the cells, which may have caused 
the tissue to contract up the post and lose its anchoring around the post.  Tissue death could 
also be due to insufficient media diffusion into the center of the tissue due to the large 
diameter of the tissue.  Native skeletal muscle fibers are 100 μm in diameter, however, the 
molding system has a diameter of 1 mm.  This discrepancy was caused by manufacturing 
limitations from the WPI machine shop, since the manufacturing of a channel less than 1 mm in 
diameter requires.  Since the diameter of the formed tissue is approximately 10X that of native 
tissue, the extra tissue may be hindering the diffusion of media, which provides nutrients, to 
the cells at the center of the tissue structure.  Cell death in the center of the tissue due to lack 
of nutrients from media could be contributing to the lack of contractile properties in the tissue.  
Modifications to the design on the molding system could be incorporated into the 
system in order to solve the problems encountered with the loss of anchoring.  By constructing 
a mold with taller anchor posts, the mold will provide a larger distance for the fiber to contract 
 105 
 
upwards on, minimizing the chance that it will completely move off the post.  Additionally, 
manufacture of the mold using more advanced technologies such as photolithography can 
allow for the development of a mold with channels of smaller diameters.  The fiber resulting 
from seeding of these molds would be thinner than the fiber produced from the current 
molding system and would allow increased media diffusion into the center of the fiber.  
Limitations to the molding system include the post height and channel width mentioned 
previously.  Other limitations include the lack of an incorporated system for mechanical 
conditioning of the fiber as it forms.  Previous studies have described the improvements in 
mechanical properties of myofibers due to dynamic mechanical conditioning.  The dog bone 
molding system is, however, amenable to mechanical conditioning due to its linear shape. 
Future groups can expand upon the current system to incorporate a system to cyclically provide 
mechanical conditioning to the tissue as it forms a myofiber in order to enhance its mechanical 
properties.  
Though the model that was developed was successful in allowing the team to meet the 
goal of achieving tissue formation, the proposed modifications could lead to its optimization.  A 
thinner channel diameter, taller posts, and the addition of a mechanical conditioning system 
could be used for the development of skeletal muscle fibers with improved properties and 
greater potential for use in research applications.  
7.2 Impact Analysis 
The group conducted an impact analysis that shows how our project relates to global 
concerns in various ways.  The topics of this analysis are: economics, environmental impact, 
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society influence, political ramifications, ethical concerns, health and safety issues, 
manufacturability, and sustainability. 
7.2.1 Economics 
The success of our product depends on how much of a need our users have for our 
product. As a design team, we must determine how much they are willing to spend on it.  If our 
product makes it very easy for the user to produce human skeletal muscle fibers, then our 
product will sell.  Furthermore, patients suffering from muscle loss may not mind paying for a 
state-of-the-art device that will help them regain some muscle mass even if is an expensive 
alternative. 
7.2.2 Environmental Impact 
The molding device will not have a significant impact on the environment.  Any potential 
effects on the environment due to our device are discussed in the sustainability section later in 
the report.  An indirect environmental impact is that if our device is successful it can improve 
and possibly extend a patient’s life.  If humans live longer, they will contribute more waste and 
use up resources at a faster rate.  This can add further stress on the economy and the non-
renewable energy sources. 
7.2.3 Societal Influence 
 The molding system can potentially have a drastic effect on a patient.  Since this system 
will allow for the regeneration of lost muscle mass, it will greatly improve the quality of life of 
the patient and the patient’s caretakers.  If the molding system goes to market, it could have a 
beneficial psychological and societal effect on certain groups such as injured soldiers and cancer 
patients.  
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7.2.4 Political Ramifications 
 Currently, the molding device does not have any political ramifications.  If, in the future, 
the device can be manufactured quickly and cost-effectively, it can have a big impact for 
soldiers and cancer patients around the world.  Not only will this device make an impact in 
European countries, but it will especially be useful in poor Asian countries that have a variety of 
muscle diseases.   
7.2.5 Ethical Concerns 
The molding device does not have many associated ethical concerns.  Since this device 
uses progenitor cell lines, people who are not fully informed about the cell types used in the 
device might think that stem cells might be used.  Stem cells represent a polarizing subject in 
biological research and thus proper presentation of the device to users and patients is 
necessary.  Another possible ethical concern is the practice of taking a patient’s cells and using 
them in a biomedical capacity.  This practice can conflict with certain individuals’ religious 
beliefs.   
7.2.6 Health and Safety Issues 
 The molding device was designed and built with the intention of improving a patient’s 
quality of life.  Theoretically, the device should improve a patient’s quality of life by aiding in 
repairing and coercing the patient’s body to regenerate lost muscle mass.  The safety of the 
device can be tested by the FDA through in-depth animal and clinical testing.  This will help the 
device earn an HCPCS code and confirm that the device is safe for patients.  An HCPCS code will 
help the device to be covered by insurance companies.    
 108 
 
7.2.7 Manufacturability 
 The manufacturing process of the molding system involves a one-time manufacture of 
an acrylic mold template, which takes about 2 hours.  The PDMS mold, which is then developed 
from the acrylic template, is then created in a process that takes about 4 hours for the PDMS to 
be de-gassed.  Finally, the agarose mold is developed in a 3 hour long process, using the PDMS 
mold as a template.  The use of a double negative template ensures that there is always a 
means to develop single negative and final molds through processes that do not involve the use 
of the machine shop and the skills of a machinist, but rather components found in the lab.  
Once one PDMS mold is made, it can be used as the template for all future agarose molds.  
Therefore, the only mold that must be continually made for each experiment is the agarose 
mold.  Additionally, the use of three dog bone molds on one block allows for the manufacture 
of three molds at once.  
 Compared to the use of scaffold systems, such as seeding cells onto microthreads, the 
manufacturability of the dog bone molding system is high because of the decreased time that it 
takes to manufacture each scaffold.  For example, the development of standard collagen 
microthreads is a three day process and each thread must be extruded by hand.  The relative 
ease of manufacture of the molding system makes it a feasible alternative to the current 
standard device.  
 7.2.8 Sustainability 
 Sustainability can be defined as using materials, processes, and systems that will not 
deplete resources or affect natural cycles.  Using this definition, the design team analyzed the 
complete process of producing a muscle fiber using a gel matrix and a dog bone molding system 
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for its conformance to sustainability.  Collagen, fibrin, agarose, and myogenic cells are naturally-
occurring.  They can be derived from animals or human patients and thus, they are renewable 
resources and will not be depleted.  The myogenic cells can regenerate while collagen, fibrin, 
and agarose can be collected in several environmentally-friendly means.  However, the master 
mold is made of acrylic, also known as PMMA.  PMMA is synthesized using petroleum, which is 
a non-renewable resource.  Hence, it is highly recommended to find an alternate material that 
has similar properties as PMMA but comes from a sustainable resource.  Finally, most of the 
culturing equipment was made of various plastics that are discarded properly and can be 
recycled at a proper facility.  All these factors make this device a very eco-friendly one and its 
sustainability is one of the added benefits of using this product.  
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Chapter 8: Conclusions and Recommendation 
 The main objective of this project was to achieve skeletal muscle tissue formation using 
a scaffold-free system.  The team developed a dog-bone shaped molding system with a channel 
for the seeding of myogenic cells and anchor posts incorporated within the mold itself. 
Experimentation with seeding densities and the use of biological gels allowed the team to 
determine the optimal conditions for fiber formation using the dog bone mold.  Assays were 
performed to characterize C2C12 cells to validate the seeding experiments and to determine 
ways to optimize the seeding process in future studies.  Overall, the team developed an 
effective way to induce skeletal muscle tissue formation in vitro and provided a platform for the 
development of skeletal muscle fibers with optimized properties in the future.  
While the goal of this project was to design a molding device that will recapitulate skeletal 
muscle fiber, this project can be expanded in various directions in the future.  One way to 
optimize the current molding system would involve the manufacture of the mold using a 
process such as photolithography.  The laser cutting process that was used to develop the dog 
bone molds in this project is not precise enough to create a smooth surface for the cell seeding 
channel.  Photolithography is unavailable using the resources at WPI, but if used, could be used 
for the development of a dog-bone mold with a smoother surface area for the cells.  The 
smoother surface area could facilitate increased cell-to-cell contact since the cells would be 
seeded onto a smooth surface, rather than one with grooves for cells to fill into.  
Additionally, the bottom of the channel of the current dog bone mold has sharp edges, as 
shown in the schematic of the cross-section of the mold shown in Figure 44.  The ideal seeding 
channel, also shown in Figure 31 has more rounded edges.  In the current system, the sharp 
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edges inhibit full cell-to-cell contact at the bottom of the seeding channel because the tissue 
that forms is rounded.  The shape of the ideal channel would more easily facilitate cell-to-cell 
contact and reduce the possibility of excluding cells at the edges of the channel from 
integrating into the tissue.  
 
 
Figure 44: Schematic of Current Seeding Channel and Ideal Seeding Channel 
 Many studies have shown that mechanical conditioning of skeletal muscle fibers can 
provide the fiber with improved mechanical properties such as higher tensile strength, 
maintenance of desired elastic modulus, and a high percent elongation until failure.  
There are many ways to mechanically condition the muscle fiber developed from the dog-
bone molding system.  One example involves the use of magnetic particles, which can be 
loaded into agarose posts.  After the muscle fiber forms, a magnet attached to an actuator can 
be used to attract the magnetic particles, and can cause the muscle fiber to stretch in a cyclic 
manner.  Another possible method is to carefully cut the agarose mold in half while keeping the 
muscle fiber intact and attached on either end to an agarose posts.  One side of the agarose 
mold can be attached to an actuator and the actuator can be used to mechanically condition 
the muscle fiber.   
Current Seeding Channel Ideal Seeding Channel 
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In this project, the muscle fiber was electrically stimulated in order to observe whether the 
muscle contracted.  More quantifiable experiments can be conducted where a force transducer 
can be used to measure any contractile forces.  Furthermore, a mechanical testing device, such 
as the Instron can be used to measure mechanical properties such as tensile strength and 
elastic modulus.  All of these mechanical properties of the engineered fiber can be compared to 
those of a native skeletal muscle fiber. 
            Reinnervation is an important process for full integration of skeletal muscle grafts and 
thus, it is important to show that the engineered muscle fiber allows for nerves to form 
neuromuscular junctions.  An experiment can be conducted in vitro where PC12 cells, a widely 
used cell line derived from rat pheochromocytoma and which serves as a standard model 
system for neurons, can be co-cultured with muscle fibers formed from C2C12 cells. 
Neuroscreen-1, a subclone of PC12, does not aggregate with itself but is still able to develop 
neurite outgrowth.  After two days, the Neuroscreen-1 cells should have enough neurite 
outgrowths to begin to form neuromuscular junctions.   
Electrical stimulation tests can be conducted to electrically stimulated neural axons to 
determine whether an action potential is generated and, consequentially, whether the muscle 
contracts.  If the engineered skeletal muscle fiber has the appropriate mechanical properties 
and allows for reinnervation, in vivo studies in rats can be conducted.  
            The ultimate end goal of this project is to regenerate human skeletal muscle that can be 
grafted into patients with muscle loss from injuries or disease.  However, in vivo studies in small 
animals and large animals must be conducted prior to human clinical trials.  The in vivo studies 
will demonstrate the degree of integration of the engineered skeletal muscle fiber into the 
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surrounding native muscle tissue.  The results of the in vivo studies can also be used to measure 
the effectiveness of the engineered muscle in recapitulating native skeletal muscle.  The in vivo 
test subjects with a muscle graft can be compared to a control group containing subjects with 
no muscle injury to determine the effectiveness of the engineered muscle in providing the 
animals with natural mobility.    
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Appendix A: C2C12 Proliferation and Differentiation Studies 
DAY 1 
 
Figure 45: Day 1 BrdU Stain (5,000 cells/well)     Day 1 Hoechst Stain (5,000 cells/well)  
  
Figure 46: Day 1 BrdU Stain (15,000 cells/well)      Day 1 Hoechst Stain (15,000 cells/well) 
  
Figure 47: Day 1 BrdU Stain (20,000 cells/well)       Day 1 Hoechst Stain (20,000 cells/well) 
 
50 µm 50 µm 
50 µm 50 µm 
50 µm 50 µm 
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DAY 2 
 
Figure 48: Day 2 BrdU Stain (5,000 cells/well)        Day 2 Hoechst Stain (5,000 cells/well) 
 
Figure 49: Day 2 BrdU Stain (15,000 cells/well)   Day 2 Hoechst Stain (15,000 cells/well) 
 
Figure 50: Day 2 BrdU Stain (20,000 cells/well)   Day 2 Hoechst Stain (20,000 cells/well) 
 
 
50 µm 50 µm 
50 µm 50 µm 
50 µm 50 µm 
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DAY 3 
 
Figure 51: Day 3 BrdU Stain (5,000 cells/well)   Day 3 Hoechst Stain (5,000 cells/well) 
 
Figure 52: Day 3 BrdU Stain (15,000 cells/well)   Day 3 Hoechst Stain (15,000 cells/well) 
 
Figure 53: Day 3 BrdU Stain (20,000 cells/well)      Day 3 Hoechst Stain (20,000 cells/well) 
 
 
50 µm 50 µm 
50 µm 50 µm 
50 µm 50 µm 
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DAY 4 
 
Figure 54: Day 4 BrdU Stain (5,000 cells/well)   Day 4 Hoechst Stain (5,000 cells/well) 
 
Figure 55: Day 4 BrdU Stain (15,000 cells/well)    Day 4 Hoechst Stain (15,000 cells/well) 
 
Figure 56: Day 4 BrdU Stain (20,000 cells/well)    Day 4 Hoechst Stain (20,000 cells/well) 
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DAY 5 
 
Figure 57: Day 5 BrdU Stain (5,000 cells/well)    Day 5 Hoechst Stain (5,000 cells/well) 
 
Figure 58: Day 5 BrdU Stain (15,000 cells/well)      Day 5 Hoechst Stain (15,000 cells/well) 
 
Figure 59: Day 5 BrdU Stain (20,000 cells/well)    Day 5 Hoechst Stain (20,000 cells/well) 
 
 
50 µm 50 µm 
50 µm 50 µm 
50 µm 50 µm 
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Appendix B: Protocols 
 
B1. Plating C2C12 Cells: 
1) Wash hands, clean hood, clean aspirating tube with 70% ethanol 
2) Aspirate media out of flask using glass pipette tip 
3) Add 2mL of PBS to rinse flask 
4) Swirl until PBS covers the surface of the plate 
5) Use a glass pipette tip to aspirate all of the PBS 
6) Add 2mL of trypsin to the flask  
7) Wait 5 minutes for the cells to detach from the plate surface and observe under 
microscope to ensure cell detachment 
8) Put 3 mL of media in the flask to neutralize the trypsin 
9) Pipette the whole solution into a 10mL conical tube 
10) Spin down the 10mL conical tube for 5 minutes at 800-1200 rpm 
11) Aspirate out the supernatant, leaving the pellet in the conical tube 
12) Add 3mL of media to resuspend the cells 
13) Pipette up and down to break the pellet and for uniform cell distribution 
14) Take a 50μL sample of media and add to Eppendorf tube 
15) Add Trypan Blue (50μL) to the Eppendorf tube containing the media and cells 
16) Mix the contents of the Eppendorf tube and remove 20μL of the solution and put in a 
hemocytometer 
17) Using the light microscope, count the number of cells and calculate the current cell 
density 
18) Based on the cell density, calculate how much media must be added to bring the cells to 
the right seeding density 
19) Based on calculations, add the calculated amount of media into a T-25 flask 
20) Seed the T-25 flask with the necessary amount of cells 
21) Lightly swirl plate to have media covering the whole surface and ensure that there are 
no bubbles 
22) Put flask in incubator at the right conditions 
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Figure 60: a) Hemocytometer b) One Grid within the Hemocytometer 
- Count the number of cells in the regions of the hemocytometer, as indicated in Figure 59.   
- For increased accuracy, count the cells in two hemocytometer blocks and take the average 
from the two blocks 
Calculations for steps 17-20 
-Divide the total number of cells counted by 2 to obtain an average 
- Divide the number of cells by 4 to account for the four boxes of the grid counted 
- Divide the number obtained by 2 to account for the dilution in Trypan Blue 
- Multiply by 10,000 to obtain the value for the total number of cells (a) 
- The optimal amount of media in a T-25 flask is 3mL, so for our protocol we are using 2.5 mL of 
media and 0.5 mL of cells 
- If (b) is the number of cells that we want to seed in our T-25 flask, and we want (b) in 0.5 mL 
of media, then our desired cell density will be       
 
 
     
    
   
   
 
- Divide a/2b to obtain the value for the amount of media to add to the tube containing the 
cells 
- Pipette up and down to ensure proper mixing 
- Add 2.5 mL of media to the T-25 flask and 0.5 mL of cells to the same T-25 flask 
- Continue from Step 21 of the protocol 
 
 
 123 
 
B2. BrdU Staining Protocol 
1. Add 1.0 µl of BrdU stock solution per ml of culture medium to cells being assayed and 
incubate for 4 hours or the time required by the experimental protocol. 
2. Aspirate culture medium and wash cells in 2X in DPBS+ 
3. Aspirate DPBS+ and add ice cold (-20C) methanol (1.0 ml/well for 24-well plate). Incubate 
for 10 min at -20C 
4. Aspirate methanol and wash with 1.0 ml PBS for10 min (plates can be stored at 4°C with 
PBS in wells if analysis is not to be done right away. 
5. Aspirate PBS and add 1.5 N HCl (0.5 ml/well for 24-well or 0.25 ml/well for 48-well plate) 
and incubate at RT for 20 min. 
6. Wash 3X with PBS, 5 min each 
7. If cells were cultured with serum, blocking is not necessary. If cultured in serum-free 
system, block at RT for at least 15 min with 5% FBS in PBS+0.05% Tween-20. 
8. Dilute anti-BrdU antibody 1:100 in PBS+0.05% Tween-20 
9. Add antibody solution (150 ul/well for 24-well plate or 75 ul/well for 48-well plate) and 
incubate at RT for 30 min. 
10. Aspirate antibody solution and wash 3X with PBS for 5 min each. 
11. Add fluorescent dye conjugated secondary-antibody diluted 1:500 in PBS+0.05% Tween-
20 (150 ul/well for 24-well plate or 75 ul/well for 48-well plate) and incubate at RT for 30 
min. 
12. Wash 3X with PBS (without Tween) 
13. Add 0.5 ug/ml Hoechst 33342 to last wash (stock is 1 mg/ml) and incubate for 10 min at 
RT 
14. Aspirate Hoechst solution, wash with PBS and add PBS (1.0 ml/well for 24-well or 0.5/well 
for 48-well plate) 
15. Cells are ready for observation by fluorescence microscopy. Plates can be stored at 4C 
wrapped in foil to protect from light.  
B3. Myosin Staining Protocol 
8. Aspirate culture medium and wash cells in 2X in DPBS+ 
9. Aspirate DPBS+ and add ice cold (-20C) methanol (1.0 ml/well for 24-well plate). Incubate 
for 10 min at -20C 
10. Aspirate methanol and wash with 1.0 ml PBS for10 min (plates can be stored at 4°C with 
PBS in wells if analysis is not to be done right away. 
11. Aspirate PBS and add 1.5 N HCl (0.5 ml/well for 24-well or 0.25 ml/well for 48-well plate) 
and incubate at RT for 20 min. 
12. Wash 3X with PBS, 5 min each 
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13. If cells were cultured with serum, blocking is not necessary. If cultured in serum-free 
system, block at RT for at least 15 min with 5% FBS in PBS+0.05% Tween-20. 
14. Dilute anti-myosin antibody 1:1000 in PBS+0.05% Tween-20 
15. Add antibody solution (150 ul/well for 24-well plate or 75 ul/well for 48-well plate) and 
incubate at RT for 30 min. 
16. Aspirate antibody solution and wash 3X with PBS for 5 min each. 
17. Add fluorescent dye conjugated secondary-antibody diluted 1:500 in PBS+0.05% Tween-
20 (150 ul/well for 24-well plate or 75 ul/well for 48-well plate) and incubate at RT for 30 
min. 
18. Wash 3X with PBS (without Tween) 
19. Add 0.5 µg/ml Hoechst 33342 to last wash (stock is 1 mg/ml) and incubate for 10 min at 
RT 
20. Aspirate Hoechst solution, wash with PBS and add PBS (1.0 ml/well for 24-well or 0.5/well 
for 48-well plate) 
21. Cells are ready for observation by fluorescence microscopy. Plates can be stored at 4C 
wrapped in foil to protect from light.  
B4. Fibrin Gel Protocol 
Materials: 
Fibrin               70 mg/ml 
Thrombin       40 U/ml  
CaCl2             40 mM 
Thaw all materials on ice and keep on ice until ready for mixing 
  
For 2 ml of total gel, use: 
  
-0.25 ml Fibrinogen stock (2X) 
  
- 212.5 μL CaCl2 (at 40 mM in DMEM) mixed with 37.5 μL Thrombin stock for 0.25 ml of a 2X 
working thrombin solution 
 
Mix the fibrinogen with the CaCl2/thrombin solution to obtain a 40 mg/mL fibrin gel. This is 4X 
higher than the concentration used in most fibrin gel protocols (10 mg/mL).  
 
Rapidly dilute the 0.25 mL of fibrin gel in 1.5 mL of media to obtain a 10 mg/mL fibrin gel 
 
The gel will take approximately 10-15 mL to polymerize, so apply the gel to the mold within this 
time period.  
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B5. Collagen Gel Protocol 
 Materials: 
Type I collagen stock solution  2 mg/mL 
Culture Medium 
FBS 
NaOH 
 
Mix each of the following components in order  
a.            420 μL Culture medium 
b.            300 μL FBS 
c.             480 μL 5X DMEM 
d.            300 μL 0.2N NaOH 
e.            1500 μL Type 1 Collagen (in 0.02N Acetic Acid) 
f.             Cell solution: Density for each mold  
  
This protocol can be used to make 3 mL of collagen gel and can be scaled down appropriately 
for smaller volumes of gel.  
B6. PDMS Protocol 
1. Place a weigh boat on top of a scale, and tare it. 
2. Determine the total weight of PDMS you wish to make and carefully pour a 10:1 ratio of 
elastomer base to curing agent in the weigh boat. For example, if you wish to make 10 
grams of PDMS, pour 18 grams of elastomer base followed by 2 grams of curing agent. 
3. Remove the weigh boat from the scale and mix well with a stirrer. The mixing creates 
bubbles which indicate good mixing. Make sure you get a lot of bubbles while mixing. 
4. Place the weigh boat containing the PDMS mixture in a plastic vacuum chamber 
(degasser), seal the chamber, and turn the vacuum valve on to connect vacuum to the 
chamber. Keep the PDMS mixture in there for one hour to eliminate the bubbles. 
5. Shut off the vacuum valve, and remove the PDMS containing weigh boat from it. 
6. Carefully pour the degased PDMS into your mold. 
7. Set the oven at 60 degrees Celsius, and place the mold in it for 4 hours to allow it to cure. 
8. After the 4 hours have passed, remove the mold from the oven, and carefully remove the 
PDMS from the mold using a spatula to gently separate it and slowly pry the newly shaped 
PDMS out. 
